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ABSTRACT 
Though many of the proteins and protein complexes involved in eukaryotic gene 
expression have been identified, mechanistic knowledge about how the proteins interact 
with and influence one another to promote gene expression remains limited. In this work, we 
have started to tease out the effects of an activator protein and the chromatin environment 
on the HAT activity of the SAGA complex. In contrast to the prevailing model of stimulation 
in which activator was believed to increase the binding affinity of SAGA for chromatin, we 
observed that activator increases the turnover rate of acetylation by SAGA on chromatin 
substrates. We have determined that this stimulation is dependent on (1) the binding of 
activator to its consensus sequence in the flanking DNA of a target nucleosome, (2) the ability 
of SAGA to compete for nucleosome binding with non-specific activator binding, and (3) the 
interaction of activator with the Tra1 subunit of SAGA. We have further analyzed the effects 
of activator on another HAT complex, the poorly-characterized ADA complex. Additionally, 
we have characterized the influence of nucleosome flanking DNA on the HAT activity of SAGA; 
the presence of flanking DNA stimulates HAT activity by increasing both binding affinity and 
turnover rate. Altogether, the work presented here suggests a model where SAGA binds to 
and acetylates nucleosomes inefficiently until it interacts with DNA-bound activators or 
exposed nucleosome flanking DNA near gene promoters. The interaction between activator 
or DNA and SAGA stimulates its HAT activity, thereby generating localized regions of 
hyperacetylation at gene promoters.  
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CHAPTER 1. INTRODUCTION 
Eukaryotic gene expression requires many factors to act in a coordinated effort to 
overcome the repressive nature of chromatin. Though many of the proteins and protein 
complexes involved in transcription initiation are known, knowledge is still limited on how they 
interact with one another and how these interactions promote gene expression. Further, the 
effects of the local chromatin environment on the activities of proteins and protein complexes 
remains to be extensively characterized. 
Chromatin 
Chromatin is a highly organized structure that packages genomic DNA into the nuclei of 
eukaryotic cells (Figure 1). Though repressive to cellular functions including transcription, DNA 
replication, and DNA repair, chromatin serves to pack two meters of negatively charged DNA into 
a sphere with a diameter of approximately 10 μm. DNA is wrapped around a spool of basic 
histone proteins to form a nucleosome, the basic building block of chromatin (Maeshima et al. 
2014; Venkatesh and Workman 2015). More specifically, in a single nucleosome, 147 base pairs 
(bps) of DNA is wrapped in a left-handed super-helix approximately 1.7-times around two each 
of histones H2A, H2B, H3, and H4. The structure of histone protein can be separated into two 
domains – a highly conserved structured domain contained within in the wrapped DNA and a 
long unstructured N-terminal domain, commonly called a histone tail (Luger et al. 1997). The 
histones tails make up 25 – 30% of the protein and extend past the wrapped DNA (Strahl and Allis 
2000). The tails are important for regulating the state of the chromatin as they can interact with 
the nucleosomal DNA, other nucleosomes, and upon being post-translationally modified (PTM), 
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many other proteins and protein complexes (Bannister and Kouzarides 2011). Between each 
nucleosome and linking one to another is approximately 20 – 80 bps of linker DNA (Maeshima et 
al. 2014).  
At its most condensed state and existing during cellular division, chromatin forms distinct 
chromosomes. When cells are not undergoing division, chromatin appears to lack higher order 
structure as previously thought (Maeshima et al. 2010), instead existing in a state of polymer 
melt (Luger et al. 2012; Maeshima et al. 2014; Ou et al. 2017). Two different regions are observed 
in this state (Ou et al. 2017): those that are denser and transcriptionally inactive are called 
heterochromatin, whereas regions which are less dense and transcriptionally active are called 
euchromatin. The structure of chromatin is not static but rather is dynamic; it can fluctuate 
between these open and closed states.  
One major mechanism influencing chromatin dynamics is the addition of post-
translational modifications (PTMs) to the tails of histone proteins. All four of the histone tails can 
be heavily modified by PTMs. These modifications include, but are not limited to, acetylation, 
methylation, and ubiquitination (Bannister and Kouzarides 2011). In 2000, it was hypothesized 
that these modifications, either alone or in a context dependent manner, constitute a histone 
code and this code regulates downstream cellular functions, including transcription (Strahl and 
Allis 2000). This hypothesis came to fruition upon the observations of both direct and indirect 
effects of the PTMs on the state of the chromatin.  
Histone acetylation is one of the most well studied PTMs of the histone tails, and both 
the direct and indirect effects of this modification have been observed in vivo and in vitro (Figure 
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2) (Verdin and Ott 2015). Histone acetylation is established by a writer enzyme called a histone 
acetyltransferase (HAT) enzyme (Brownell et al. 1996). The acetylation of the lysines in the 
histone tails directly changes the state of the chromatin by neutralizing lysines charge and 
resulting in the histone tails releasing their hold on the nucleosomal DNA. Because of this event, 
the chromatin decompacts and adopts the open, or transcriptionally active, state. Acetylation of 
the histone tails can also indirectly influence the state of the chromatin by serving as a platform 
upon which reader proteins and protein complexes bind and actively alter the chromatin state 
or promote transcription initiation. Proteins which dock at the acetylated lysines harbor a 
bromodomain which is specific for this PTM. The deacetylation of the histone tails is performed 
by eraser enzymes, specifically histone deacetylases (HDACs) (Verdin and Ott 2015). The removal 
of the acetyl groups promotes the formation of the closed state of the chromatin and correlates 
to gene expression being off. 
From this example, it can be extrapolated that other modifications influence the 
chromatin state to either promote or repress downstream cellular functions. Additionally, the 
recent literature shows that the majority of these writer, reader, and eraser functions do not 
exist on separate entities but rather are coalesced into large, multi-protein complexes. This gives 
rise to yet another level of influence that the PTMs of histone tails play on the dynamic structure 
of the chromatin; a complex may contain writer, reader, and eraser functions for different 
modifications. Multiple examples of histone modification cross talk can be found in recent 
literature. For example, during transcription initiation, ubiquitination of lysine 123 on histone 
H2B is established prior to the di- or trimethylated lysine at position four on histone H3. This in 
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turn promotes the deposition of acetyl groups onto multiple lysines on the histone H3 tail 
(Bannister and Kouzarides 2011). While crosstalk has been observed at qualitative levels, it 
remains to be fully elucidated their role in the activity of the writer enzymes.  
SAGA 
The SAGA family of transcriptional coactivators are large, multi-subunit complexes that 
are highly conserved across eukaryotes (Nagy and Tora 2007). In yeast, SAGA has been shown to 
be important for the inducible transcription of genes which respond to stress signals (Huisinga 
and Pugh 2004). In higher eukaryotes, SAGA plays additional roles in the transcription of genes 
in response to developmental cues (Spedale et al. 2012). Indeed, aberrant expression and 
subsequent misregulation of subunits in SAGA result in larval arrest in Drosophila melanogaster 
and embryonic cell death in mice (Xu et al. 2000; Carre et al. 2005; Bu et al. 2007). Further, 
polyglutamine expansion of ATXN7, the human homolog of yeast Sgf73, are associated with the 
neurodegenerative disease, spinocerebellar ataxia type 7 (McMahon et al. 2005; Palhan et al. 
2005; Burke et al. 2013). SAGA doesn’t only function in eukaryotic gene expression; it also has 
been shown to be involved in mRNA export (Rodriguez-Navarro et al. 2004; Kohler et al. 2008; 
Garcia-Oliver et al. 2012), DNA repair (Ghosh and Pugh 2011), and telomere maintenance 
(Atanassov et al. 2009). 
Structure 
The large molecular weight and complex protein composition of SAGA renders traditional 
biophysics techniques, such as x-ray crystallography and nuclear magnetic resonance (NMR), 
inadequate for analysis of the entire complex. However, these techniques have been used to 
12 
 
study individual domains and subunits of SAGA (Dhalluin et al. 1999; Kohler et al. 2010; Samara 
et al. 2010). Electron microscopy (EM) instead has been used to study the molecular architecture 
of SAGA, and has yielded structures that are modular in their organization (Figure 3) (Wu et al. 
2004; Durand et al. 2014; Setiaputra et al. 2015). Quantitative proteomics and cross-linking mass 
spectrometry (CXMS) studies furthered these observations and established subunit interaction 
networks, separating SAGA into four distinct structural and functional modules (Figure 4) (Lee et 
al. 2011; Han et al. 2014; Nguyen-Huynh et al. 2015; Setiaputra et al. 2015). These include the 
suppressors of Ty insertions (Spt), TATA-binding protein (TBP) associated factors (Taf), 
deubiquitination (DUB) modules, and histone acetyltransferase (HAT). Generally, SAGA possesses 
two lobes. One lobe encompasses the 433 kDa protein Tra1, while the remaining modules reside 
in the second lobe that is conformationally flexible (Wu et al. 2004; Setiaputra et al. 2015; Sharov 
et al. 2017). Septiaputra et al have observed that the two enzymatic activities and many of the 
chromatin interacting domains of SAGA all reside on a single face of the complex in the flexible 
lobe, potentially enabling SAGA to sample a variety of nucleosome substrates (Setiaputra et al. 
2015).  
The Spt module contains four proteins (Spt3, Spt7, Spt8, and Spt20) that were originally 
identified in a yeast genetic screen as suppressors of Ty insertions in gene promoters (Winston 
and Sudarsanam 1998). Also included in this module are the subunits Ada1 and Tra1 (Horiuchi et 
al. 1997; Saleh et al. 1998; Lee et al. 2011; Han et al. 2014). Subunits Spt3 and Spt8, in 
coordination with Spt20 and Spt7, respectively, have been shown to interact with TBP (Bhaumik 
and Green 2002; Mohibullah and Hahn 2008; Han et al. 2014). These interactions play complex 
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roles in gene regulation, imparting either positive or negative effects on transcription (Bhaumik 
2011). In addition to interacting with TBP, the Spt module can interact with acetylated lysines via 
the bromodomain within the N-terminal half of Spt7 (Hudson et al. 2000). However, deletion of 
the bromodomain of Spt7 doesn’t change targeting or retention of SAGA on nucleosome arrays, 
suggesting divergent roles of bromodomains in chromatin associating proteins (Hassan et al. 
2002). Deletion of the C-terminal half of Spt7 results in loss of Spt8 in SAGA (Pray-Grant et al. 
2002; Wu and Winston 2002). Indeed, the C-terminal half of Spt7 cross-links to the WD40 
domains of Spt8 (Han et al. 2014). This complex is known as the SAGA-like (SLIK) complex, and 
SAGA can be selectively purified from this highly related complex via addition of a TAP tag to the 
C-terminal of Spt7 (Wu and Winston 2002) or by application of complexes to an anion column 
(Lee et al. 2004). Subunits Ada1, Spt7, and Spt20 play roles in the structural integrity of SAGA as 
deletions of either strain cause disruptions in SAGA purifications (Sterner et al. 1999). Finally, the 
Tra1 subunit interacts with transcriptional activators, such as VP16 and yeast activators Gal4 and 
Gcn4 (Kuo et al. 2000; Brown et al. 2001; Larschan and Winston 2001). Recent cryo-EM structures 
have solved the structure of Tra1 to a resolution of 3.7A and 5.7A, and have confirmed that Tra1 
resides in one entire lobe at the periphery of SAGA (Diaz-Santin et al. 2017; Sharov et al. 2017), 
as suggested by previous studies (Wu et al. 2004; Lee et al. 2011; Han et al. 2014). 
The Taf module is comprised of Taf5, Taf6, Taf9, Taf10, and Taf12 (Grant et al. 1998). It is 
proposed that these proteins, in combination with Ada1 and Spt7 (Gangloff et al. 2001), form a 
core that is structurally similar to that solved for TFIID (Bieniossek et al. 2013). In TFIID, two copies 
each of Taf4, Taf5, Taf6, Taf9, and Taf12 form a symmetric core, and the addition of a single 
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histone fold pair Taf8 and Taf10 results in an asymmetric configuration of the complex 
(Bieniossek et al. 2013). Rather than Taf10 and Taf12 pairing with Taf8 and Taf4, respectively, 
they pair with Spt7 and Ada1 through their histone fold domains (Gangloff et al. 2001). However, 
the copy number of each Taf protein in a single SAGA complex is still debated; early EM studies 
identified two distinct locations for Taf6 and Taf10 using targeted antibodies (Wu et al. 2004) 
while introduction of GFP tags to the C-termini of Taf5 and Taf9 did not yield unambiguous 
densities for the proteins (Setiaputra et al. 2015). Further, the highly symmetric Taf core of TFIID 
could not be placed within the enzymatic lobe of a cryo-EM structure of SAGA (Sharov et al. 
2017).  
Of the four modules of SAGA, only the structure of the DUB module has been solved by 
crystallography (Kohler et al. 2010; Samara et al. 2010). The subunits of this module include the 
ubiquitin protease, Ubp8, as well as Sgf11, Sgf73, and Sus1 (Henry et al. 2003; Daniel et al. 2004). 
Ubp8 requires all subunits of the module for its activity (Kohler et al. 2008); the four proteins are 
heavily intertwined into two functional lobes that are anchored to SAGA via the C-terminal half 
of Sgf73 (Kohler et al. 2010; Samara et al. 2010). Further, the enzymatic activity of Ubp8 is 
separable from SAGA (Lim et al. 2013). Sgf11 and Sgf73 both possess zinc finger domains which 
interact with nucleosomes (Bonnet et al. 2010; Koehler et al. 2014). NMR studies of the zinc finger 
domain of Sgf11 observed that it bound DNA (Koehler et al. 2014), albeit weakly. Conversely, 
Morgan et al determined the zinc finger domain bound the H2A/H2B dimer interface rather than 
nucleosomal DNA (Morgan et al. 2016). Two zinc finger domains have been identified in Sgf73, 
though only one has been shown to bind nucleosomes (Bonnet et al. 2010; Koehler et al. 2014). 
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The N-terminal zinc finger domain is required for the assembly and association of the DUB 
module to SAGA (Kohler et al. 2008; Kohler et al. 2010; Samara et al. 2010). The second zinc finger 
domain in Sgf73 is commonly known as the SCA7 domain and has been shown to recruit 
nucleosomes to the DUB module (Helmlinger et al. 2004; Bonnet et al. 2010). Polyglutamine 
expansions of the SCA7 domain in Sgf73 and its homolog ATXN7 result in the neurodegenerative 
disease spinocerebellar ataxia type 7 (SCA7) (McMahon et al. 2005; Helmlinger et al. 2006; Lan 
et al. 2015). Though little information is available about structural domains of the final subunit 
of the DUB module, Sus1 plays a role in mRNA export from the nucleus (Rodriguez-Navarro et al. 
2004). 
The HAT module is the final module in SAGA and is made of four subunits, the 
acetyltransferase enzyme, Gcn5, Ada2, Ada3, and Sgf29 (Lee et al. 2011). The Ada 
(alteration/deficiency in activation) proteins were identified as coactivator proteins required for 
bridging interactions between activators and transcriptional machinery (Berger et al. 1992; Pina 
et al. 1993; Marcus et al. 1994). Ada2 and Ada 3 form a trimeric complex with Gcn5 with Ada2 
bridging interactions between Gcn5 and Ada3 (Horiuchi et al. 1995; Han et al. 2014; Nguyen-
Huynh et al. 2015). Ada2 and Ada3 are also required for the expanded specificity of Gcn5, 
enabling it to acetylate the four primary lysines on free and nucleosomal histone H3 like SAGA 
(Grant et al. 1999; Balasubramanian et al. 2002). Two putative nucleosome binding domains exist 
in Ada2; the SANT domain has been shown to promote Gcn5 activity via binding of histone tails 
(Boyer et al. 2002; Sterner et al. 2002), while the SWIRM domain binds DNA (Qian et al. 2005; Da 
et al. 2006). The catalytic domains of yeast Gcn5, Tetrahymena Gcn5 with CoA and H3 peptide, 
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and PCAF, a Gcn5 family member, with CoA have been determined (discussed in Enzymatic 
activities: HAT activity; (Clements et al. 1999; Rojas et al. 1999; Trievel et al. 1999). C-terminal to 
the HAT domain of Gcn5 is a bromodomain; deletion of the bromodomain decreases the 
acetyltransferase activity of SAGA on nucleosomes and reduces the retention of SAGA on 
nucleosome arrays (Josling et al. 2012). Recently, Sgf29 was found to associate with the HAT 
module (Lee et al. 2011), interacting with Ada3 as determined by CXMS analysis (Han et al. 2014; 
Nguyen-Huynh et al. 2015). Within Sgf29 resides a tandem Tudor domain, a domain which binds 
specifically to di- or trimethylated lysines (Bian et al. 2011). 
Enzymatic activities 
HAT activity  
Gcn5 catalyzes the transfer of an acetyl group from acetyl coenzyme A (acetyl CoA) to the 
ɛ-amine group of lysine 14 on histone H3 (H3K14ac) (Kuo et al. 1996; Grant et al. 1999). Two 
possible mechanisms can describe this reaction. In one, a covalent enzyme intermediate is 
formed; the acetyl group of acetyl CoA is transferred to a nucleophile in the enzyme prior to the 
transfer of the acetyl group to the lysine on the histone. This mechanism is also known as a ping-
pong mechanism. Alternatively, the acetyl group is directly transferred to the lysine on the 
histone through the formation of a ternary structure. This mechanism is sequential and can be 
either random or ordered (Tanner et al. 1999; Tanner et al. 2000b). 
To distinguish between the two mechanisms, Tanner, et. al., identified the initial rate 
kinetic parameters of Gcn5 for acetyl CoA and both core histones (Tanner et al. 1999) and H3 
peptide (Tanner et al. 2000b). Double reciprocal plots (1/velocity against 1/[core histones] or [H3 
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peptide]) at fixed concentrations of acetyl CoA  yielded an intersecting line pattern, indicative of 
a sequential mechanism. Product inhibition studies further supported this mechanism; CoA was 
determined to be a competitive inhibitor of acetyl CoA and H3 peptide containing K14ac was 
noncompetitive for both acetyl CoA and H3 peptide. Further, the binding affinity of Gcn5 for CoA 
was like that found for acetyl CoA (Tanner et al. 2000b). Subsequent studies of the 
acetyltransferase domain of PCAF, which has 43% identity to the catalytic domain of Gcn5, 
yielded the same mechanism (Tanner et al. 2000a).  
Additional structural and kinetic studies also favor of this mechanism. For the direct 
transfer of the acetyl group from acetyl CoA to H3K14, the lysine must first be deprotonated. 
Crystal structures of the acetyltransferase domains of PCAF, yeast Gcn5 (yGcn5), and 
Tetrahymena Gcn5 (tGcn5) identify potential general bases (Glu570, Glu173, and Glu122, 
respectively) which could facilitate the proton abstraction from H3K14 (Clements et al. 1999; 
Rojas et al. 1999; Trievel et al. 1999). These residues are strictly conserved between the 
acetyltransferase domains, and are surrounded by conserved hydrophobic residues (Clements et 
al. 1999; Rojas et al. 1999). In the binary structure of PCAF/CoA (Clements et al. 1999) and the 
ternary structure of tGcn5/CoA/H3 peptide (Rojas et al. 1999), a water molecule is present 
adjacent to the general bases between them and the H3K14 binding site. Thus, proton extraction 
may occur indirectly via the water molecule. Finally, mutation of yGcn5 Glu173 to Gln altered the 
catalytic activity of Gcn5 but not its binding affinity for substrates, indicating this conserved 
residue is the general base for Gcn5 (Tanner et al. 1999). The culmination of these results 
supports an ordered bi-bi reaction mechanism in which Gcn5 first binds acetyl CoA and then 
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histone H3 to form a ternary complex, followed by the release of acetylated histone H3 and finally 
CoA; the direct transfer of the acetyl group is mediated by the general base Glu173. 
In contrast to Gcn5 which only targets H3K14 on H3 peptides or on free histones, SAGA 
acetylates four primarily residues, H3K9, K14, K18, and K23, on H3 peptides, free histones, and 
nucleosomal histones (Grant et al. 1999; Balasubramanian et al. 2002). Additionally, SAGA also 
acetylates non-histone proteins, including the activators p53 (Barlev et al. 2001) and Myc (Patel 
et al. 2004). The 800 kDa ADA complex, which shares its HAT module with SAGA, also targets 
H3K14, K18, and to a lesser extent K9 and K23 (Grant et al. 1999). Balasubramanian, et. al., 
pursued the roles of Ada2 and Ada3 in histone acetylation to determine if these subunits 
contributed to the expanded specificity of SAGA (Balasubramanian et al. 2002). Indeed, a 
subcomplex of Ada2-Gcn5 had approximately 5-times higher activity on free histones compared 
to Gcn5 alone, concluding that Ada2 potentiates the activity of Gcn5 on free histones. 
Additionally, a subcomplex of Ada2-Ada3-Gcn5 could acetylate nucleosome substrates 15-times 
better than Ada2-Gcn5 and 100-times better Gcn5 alone (Balasubramanian et al. 2002). These 
studies also found that SAGA preferentially acetylates lysines in H3 peptide in the following order:  
K14 > K18 > K9 ≈ K23 (Grant et al. 1999; Balasubramanian et al. 2002). Conversely, a recent study 
describes the order of acetylation on H3 peptide by Ada2-Ada3-Gcn5 subcomplex to be K14 > 
K23 > K9 ≈ K18 > K27 > K36 (Cieniewicz et al. 2014). However, this may be due to additional 
regulation imparted by Gcn5 encompassed in SAGA compared to the subcomplex. 
In nucleosomes, SAGA can target at least four primary lysines on histone H3, and 
therefore at least eight per nucleosome (Grant et al. 1999; Balasubramanian et al. 2002). This 
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observation, coupled with the fact that Gcn5 contains a bromodomain, a binding domain specific 
for acetylated lysines (Dhalluin et al. 1999; Hassan et al. 2007), led to the hypothesis that the 
expanded specificity of SAGA could come from the ability of the bromodomain binding to and 
promoting subsequent acetylations of the nucleosome. Indeed, numerous studies have 
supported this idea. The Gcn5 bromodomain is necessary for Gcn5-containing SAGA 
subcomplexes to facilitate high levels of acetylation (Sterner et al. 1999). Work from our group 
has shown that existing acetylation in one H3 tail can promote further nucleosome acetylation in 
a bromodomain-dependent manner (Li and Shogren-Knaak 2009). Further, deletion of the 
bromodomain of Gcn5 also results in decreased acetylation in vitro; the subcomplex Ada2-Ada3-
Gcn5-bromodomain mutant, while able to target H3K14 and K23 to wild type levels, is unable to 
acetylated H3K9, K18, K27, and K36 to wild type levels (Cieniewicz et al. 2014). In these processes, 
stimulation of nucleosome acetylation by SAGA could occur after initial acetylation (H3K14ac) 
and the subsequent preferential rebinding of the acetylated lysine by the Gcn5 bromodomain in 
a two-step model (Cieniewicz et al. 2014).  
Alternatively, multiple acetylations could occur processively, where multiple nucleosome 
lysines become acetylated within a single SAGA binding event. Such a mechanism has been 
observed; the subcomplex Ada2-Ada3-Gcn5-Sgf29 processively acetylates nucleosomes 
trimethylated at H3K4 (H3K4me3) even in the presence of competitor nucleosomes (Ringel et al. 
2015). Processivity of Gcn5 is diminished when the tandem Tudor domain of Sgf29, a domain 
which specifically binds H3K4me3, is deleted, and when the bromodomain of Gcn5 is deleted 
(Ringel et al. 2015). We have recently observed that SAGA exhibits burst phase kinetics on 
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nucleosomes, indicative that the activity of SAGA proceeds along one of these pathways (Mittal 
et al, submitted). 
In the late 1990s, it was observed that there were regions of hyperacetylation on histone 
H3 in promoter regions of numerous inducible genes in budding yeast, and that this modification 
was dependent on SAGA (Kuo et al. 1998; Krebs et al. 1999). Subsequent studies observed that 
DNA-binding proteins called activators bound consensus DNA in upstream activating sequences, 
and upon their deletion, there was a concurrent decrease in the levels of hyperacetylation and 
transcription initiation (Utley et al. 1998; Ikeda et al. 1999; Kuo et al. 2000; Vignali et al. 2000). 
This lead to the general hypothesis that activators recruited SAGA to inducible gene promoters 
to acetylate histone H3 and promote gene expression.  
As genome-wide transcriptome analyses became established, this model was expanded 
and genes became categorized as either SAGA- or TFIID-dominant. SAGA-dominated genes were 
characterized as those containing TATA-boxes and, through recruitment by activators, those 
induced by external stimuli or developmental cues. These genes accounted for approximately 
10% of the budding yeast genome. Conversely, the remaining 90% of the genome was TFIID-
dominant. These genes included those constitutively expressed and lacking TATA-boxes 
(Basehoar et al. 2004; Huisinga and Pugh 2004). In addition to the differences in DNA elements 
(i.e. TATA-box), further studies found that the chromatin structure of SAGA- and TFIID-dominant 
genes were also different. SAGA-dominated genes had poorly positioned nucleosomes in their 
promoters while the TFIID-dominated genes tended to have a nucleosome free region upstream 
of a strongly positioned +1 nucleosome and the transcriptional start site (Rhee and Pugh 2012). 
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Recently, new techniques, such as chromatin endogenous cleavage with subsequent DNA 
sequencing (ChEC-seq), have demonstrated that SAGA and TFIID, as well as Mediator, are 
localized to the promoter regions of nearly all genes in budding yeast (Grunberg et al. 2016; 
Baptista et al. 2017; Warfield et al. 2017). The authors argue that ChEC-seq has significant 
advantages over chromatin immunoprecipitation-seq (ChIP-seq): no crosslinking occurs; no 
antibodies are used; ChEC-seq could potentially capture interactions of highly dynamic 
complexes with the chromatin (Baptista et al. 2017; Taatjes 2017; Vosnakis et al. 2017). Via the 
analysis of newly synthesized mRNA rather than steady state levels of mRNA, Baptista et al also 
observed that global levels of mRNA were significantly decreased in gcn5-deleted yeast strains 
(Baptista et al. 2017). Concurrently, the acetylation of histone H3K9 were strongly decreased in 
in the same strains (Baptista et al. 2017); acetylation of histone H3K9 by SAGA was also previously 
observed at most active gene promoters (Bonnet et al. 2014). These new results argue against 
the prevailing model of independent SAGA- and TFIID-dominated genes and for a model where 
the two complexes, plus Mediator and others, work in a coordinated fashion to promote 
eukaryotic gene expression.  
DUB activity 
Monoubiquitination of histone proteins often serves in signaling pathways rather than 
degradation pathways. Ubiquitination of histone H2BK123 in yeast is established by the 
Rad6/Bre1 (E2/E3) ubiquitin ligation pair and functions in multiple cellular processes including 
transcription, DNA repair, DNA replication, and RNA processing and export (Wood et al. 2005). 
H2BK123 monoubiquitination also promotes crosstalk between PTMs; ubiquitination promotes 
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the establishment of histone H3K4 methylation by Set 1 in the COMPASS complex (Lee et al. 
2007), a modification to which SAGA specifically binds for subsequent acetylation of histone tails 
(Bian et al. 2011; Ringel et al. 2015). SAGA deubiquitinates monoubiquitinated histone H2BK123 
in yeast via the enzyme Ubp8 (Henry et al. 2003; Daniel et al. 2004). For activity, Ubp8 must be 
organized into the DUB module (Kohler et al. 2008). Crosslinking data shows a network of 
interactions between the DUB and HAT modules, and mutations to the DUB module alter the 
HAT activity of SAGA (Han et al. 2014).  
Activator interactions 
Gene activator involves a series of sequential recruitment events. In the first steps of this 
process, transcriptional activators bind to DNA sequences near their target genes via their DNA-
binding domains (DBDs). Subsequent steps lead to the recruitment of coactivators and the 
general transcription machinery by the transcription activation domains (TADs) of activators, and 
ultimately results in the formation of the pre-initiation complex at the gene promoter (Ptashne 
and Gann 1997). In the case of SAGA, numerous studies demonstrate that the complex is 
recruited, both in vivo and in vitro, to chromatin by activator proteins (Utley et al. 1998; Ikeda et 
al. 1999; Vignali et al. 2000; Bhaumik and Green 2001; Larschan and Winston 2001), and that this 
recruitment leads to localized areas of hyperacetylation on histone H3 (Utley et al. 1998; Ikeda 
et al. 1999; Kuo et al. 2000; Vignali et al. 2000) and stimulated transcription (Kuo et al. 1998; 
Utley et al. 1998; Ikeda et al. 1999; Vignali et al. 2000). 
Broadly, transcriptional activators are categorized by their TADs into three groups: acidic, 
glutamine-rich, and proline-rich. Acidic activators are characterized as having at least one critical 
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hydrophobic residue and many acidic side chains in their TADs, albeit little sequence conservation 
existing between them. The TADs of acidic activators have also been shown to be unstructured 
in solution; formation of alpha helices are induced upon binding to target proteins (McEwan et 
al. 1996; Uesugi et al. 1997). This characteristic enables acidic activators to bind to multiple 
coactivator complexes. For example, the budding yeast activator Gal4 has been shown to interact 
with SAGA (Brown et al. 2001; Bhaumik et al. 2004), Mediator (Larschan and Winston 2001; 
Bryant and Ptashne 2003), NuA4 (Reeves and Hahn 2005), and SWI/SNF (Yudkovsky et al. 1999). 
SAGA has been shown to bind to numerous acidic activators that function both in 
response to stress and to the cell cycle. In yeast, SAGA interacts with Gal4 and Gcn4 (Kuo et al. 
2000; Reeves and Hahn 2005). Gal4 exists as a dimer and controls genes which are turned on in 
the presence of galactose; Gal3 dislodges Gal80 from the Gal4 dimer, thereby freeing the TADs 
to bind coactivators (Traven et al. 2006; Hong et al. 2008). Like Gal4, Gcn4 is also a dimer and 
regulates the expression of biosynthetic genes in response to amino acid starvation (Hope and 
Struhl 1987; Hinnebusch and Natarajan 2002). In higher eukaryotes, human SAGA (STAGA) has 
been shown to interact with c-Myc and p53 (Thut et al. 1995; McMahon et al. 2000; Gamper and 
Roeder 2008; Zhang et al. 2014). c-Myc is an oncoprotein that regulates cell growth, 
differentiation, and apoptosis, and p53 is a tumor suppressor that mediates cell cycle arrest and 
apoptosis. SAGA also interacts with the TADs of herpes simplex virus VP16 (Brown et al. 2001). 
In yeast genetic screens, the TADs of VP16 are often fused to DBD of other activators, such as the 
chimeric protein Gal4-VP16 (Sadowski et al. 1988; Berger et al. 1990); subunits of SAGA were 
indeed identified through this screen (Berger et al. 1992; Pina et al. 1993).  
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The Tra1 subunit of SAGA and its human homolog TRRAP have been identified in multiple 
studies as the primary candidates which interact with activators (McMahon et al. 1998; Saleh et 
al. 1998; Brown et al. 2001; Reeves and Hahn 2005; Knutson and Hahn 2011; Zhang et al. 2014); 
Tra1 is pulled down by the TADs of Gal4, Gcn4, and VP16 (Brown et al. 2001; Knutson and Hahn 
2011) and TRRAP interacts with c-Myc (McMahon et al. 1998; Zhang et al. 2014). The structural 
organization of SAGA positions Tra1 in such a manner that it could readily interact with activators. 
Electron microscopy studies demonstrate that SAGA is composed of two main lobes, and that 
one entire lobe consists of the 433 kDa Tra1 subunit (Wu et al. 2004; Setiaputra et al. 2015; Diaz-
Santin et al. 2017; Sharov et al. 2017). A study which coupled cross-linking and mass spectrometry 
supported that Tra1 is found at the periphery of SAGA (Han et al. 2014). Interestingly, mutations 
to Tra1 have altered the acetyltransferase activity of Gcn5 (Knutson and Hahn 2011), suggesting 
that an allosteric change may occur in SAGA upon binding to activators. 
Numerous other subunits of SAGA have been implicated in binding to TADs of activators. 
Early studies observed binding of Ada2 to Gal4 and VP16 (Barlev et al. 1995). Though this 
observation was not seen in Brown et al’s studies of the subcomplex Ada2-Ada3-Gcn5 (Brown et 
al. 2001), it was detected again when recombinantly expressed Ada2 cross-linked to Gal4 and 
VP16 TADs (Klein et al. 2003). This suggest that the activator interacting surface of Ada2 is 
obscured when it is incorporated into SAGA. Also, the human variant of Ada2, Ada2b, binds to 
the C-terminal region of p53, but not to its TAD (Gamper and Roeder 2008). That Ada2 binds 
activators is supported by the observation that a yeast ada2∆ strain has decreased transcription 
activation by Gal4-VP16 and Gcn4 (Drysdale et al. 1995). 
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Additionally, multiple TAF subunits of SAGA have been detected in protein interaction 
studies. In one, the TADs of VP16 and Gal4 were cross-linked to subunits within SAGA; Ada1, Taf6, 
and Taf12 were all determined to be bound by the dimeric activators (Klein et al. 2003). Further, 
Taf12 was detected in a separate study in which the Gal4 TAD again cross-linked to the subunit 
(Reeves and Hahn 2005). Taf9 has also been suggested to bind to acidic activators; the TADs of 
VP16 and p53 directly interact with human and drosophila Taf9 (Uesugi et al. 1997; Gamper and 
Roeder 2008), a result confirmed by a pull down of VP16 with drosophila Taf9 and the 
complimentary assay of Taf9 pulling down Gal4-VP16 (Goodrich et al. 1993). 
Finally, c-Myc and p53 cross-link to human Gcn5L, the acetyltransferase enzyme of human 
STAGA and its yeast counterpart, SAGA (Gamper and Roeder 2008; Zhang et al. 2014). Though 
human Gcn5 contains an N-terminal PCAF domain that yeast Gcn5 does not (Koutelou et al. 2010; 
Nguyen-Huynh et al. 2015), Zhang et al localized the interaction between c-Myc and human Gcn5 
to the HAT and Ada2-interacting domains (Zhang et al. 2014). This result was also observed in the 
interaction between p53 and Gcn5; the variant Gcn5S which lacks the PCAF domain bound p53 
the same as Gcn5L (Gamper and Roeder 2008). 
Chromatin interactions 
DNA binding 
Numerous coactivator complexes have been shown to be sensitive to nucleosome 
flanking DNA, and putative DNA binding domains within subunits of SAGA have been identified. 
These domains may enable SAGA to preferentially acetylate nucleosomes with nucleosomal 
flanking DNA. The Swi3/Rsc9/Moira (SWIRM) domain of mouse Ada2α, a subunit required for the 
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expanded specificity of Gcn5 (Balasubramanian et al. 2002), was shown to bind double stranded 
DNA and a dinucleosome substrate with approximately 165 bp of linker DNA, but does not bind 
a single nucleosome that lacked flanking DNA (Qian et al. 2005). The zinc finger domain of Sgf11 
is another putative DNA binding domain in SAGA. Sgf11 associates with Ubp8, a subunit which 
performs the second catalytic activity of SAGA, the deubiquitination of histone H2B (Kohler et al. 
2010; Samara et al. 2010). NMR titration experiments demonstrate that the zinc finger domain 
can weakly bind double stranded DNA, but strongly bind nucleosomes (Koehler et al. 2014). 
However, this tight binding of nucleosomes may not result from DNA binding but from interaction 
of the domain with the acidic patch on the H2A/H2B dimer (Morgan et al. 2016). Further, both 
fission yeast and human TFIID has been shown to make interactions with the DNA beyond TATA-
binding protein (TBP) interactions (Elmlund et al. 2009; Cianfrocco et al. 2013). SAGA shares a 
core of TBP-associated factors (TAFs) with TFIID that act as a scaffold for assembly of other 
proteins, some of which may also interact with the DNA (Bieniossek et al. 2013; Han et al. 2014). 
Histone binding 
SAGA contains multiple domains which interact with histone proteins and specific PTMs 
on the histone tails. A crystal structure of the DUB module bound to a ubiquitinated nucleosome 
shows that the zinc finger domain of interacts with the acidic patch on the H2A/H2B dimer 
(Morgan et al. 2016). Further, the SCA7 zinc finger domain of yeast Sgf73 and human ATXN7, also 
in the DUB module, has been shown to interact with nucleosomes via pull down assays and NRM 
analysis (Bonnet et al. 2010). The SANT domain of Ada2 has also been characterized as a putative 
histone tail binding module; HAT complexes with deleted SANT domains have reduced binding 
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affinity for unacetylated histone H3 tails. Additionally, Ada2 enhances the activity of Gcn5 on H3 
peptides, core histones, and nucleosomes, and this stimulation is lost upon deletion of the SANT 
domain (Boyer et al. 2002). 
Two subunits in SAGA, Gcn5 and Spt7, possess bromodomains, domains which specifically 
bind to acetylated lysines (Hudson et al. 2000; Owen et al. 2000). However, only the 
bromodomain on Gcn5 is required for anchoring SAGA to acetylated nucleosomes; deletion of 
the bromodomain of Spt7 had no effect on binding (Hassan et al. 2002). SAGA can also bind 
specifically to a di- or trimethylated H3K4 via a tandem Tudor domain in Sgf29 (Bian et al. 2011). 
This domain is required for maintaining wild-type levels of SAGA-dependent acetylation of 
histone H3 in vivo, potentially because SAGA preferentially acetylates methylated H3K4 
nucleosomes (Bian et al. 2011; Ringel et al. 2015). Finally, WD40 domains in transcriptional 
coactivators have been shown to interact with methylated lysines on histone tails (Yun et al. 
2011), and one WD40 domain exists in Spt8 (Lee and Workman 2007). Interestingly, a EM 
structure sampling the conformational flexibility of SAGA observed that the bromo-, tandem 
Tudor, SANT, SWIRM, and WD40 domains all exist on a single edge of the SAGA complex (Figure 
5) (Setiaputra et al. 2015). 
Organization of thesis 
This dissertation has been organized into five different chapters. Chapter 1 is an 
introduction to and a literature review of the structure of chromatin and the transcriptional 
coactivator complex SAGA. Chapter 2 describes our initial research on the stimulation of SAGA 
HAT activity by nucleosome flanking DNA and an activator protein. In this work, Chitvan Mittal 
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characterized the stimulation of SAGA HAT activity on GBY and 147 bp nucleosomes, mapped the 
flanking DNA requirements for stimulation of HAT activity, and developed the pre-steady state 
acetylation assays on GBY and 147 bp nucleosomes. She also observed stimulation of HAT activity 
by activator. I generated the majority of the DNA fragments which enabled Chitvan to map the 
flanking DNA. I also performed the electrophoretic mobility shift assays, completed saturation 
curves of SAGA on nucleosome substrates with and without activator, and further characterized 
the stimulation of HAT activity by activator, including performing numerous controls and 
analyzing the pre-steady state kinetics. Additional experiments requested by reviewers are being 
performed at this time and the paper will soon be resubmitted to the Journal of Biological 
Chemistry. The mechanism of stimulation of HAT activity by activator protein is expanded upon 
in Chapter 3. This works is nearly completed and will be submitted for publication shortly after 
this defense. In Chapter 4, our current and future work is described. Chapter 5 summarizes all 
the conclusions reached in our studies and are fit into eukaryotic gene expression. 
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Figures 
 
 
Figure 1. Chromatin structure (Fyodorov et al 2017). 
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Figure 2. Histone acetylation directly alters the state of the chromatin by neutralizing interactions 
of histone tails with DNA and indirectly by serving as a binding platform for other protein 
complexes to bind (Verdin and Ott, 2015). 
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Figure 3. Cryo-EM structure of SAGA depicts two lobes. Approximate locations of specific 
modules or subunits specified based on literature (Sharov et al 2017). 
  
41 
 
 
Figure 4. SAGA has four functional modules:  HAT module (green), DUB module (purple), Spt 
module (orange), and Taf module (blue; Lee et al 2011). 
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Figure 5. Chromatin binding domains cluster on one edge of SAGA complex (Septiaputra et al 
2015). 
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Abstract 
The SAGA family of transcriptional coactivators are prototypical nucleosome 
acetyltransferase complexes that regulate multiple steps of gene transcription. The size and 
complexity of both the SAGA enzyme and the chromatin substrate provide opportunities to 
regulate the acetylation process. To better probe this regulation, we have characterized the 
44 
 
binding interactions and kinetics of acetylation using different nucleosomal substrates and the 
full SAGA complex purified from budding yeast. We find that SAGA-mediated nucleosome 
acetylation is stimulated up to 9-fold by DNA flanking the nucleosome, both by facilitating the 
binding of SAGA and by accelerating acetylation turnover. This stimulation requires flanking DNA 
on both sides of the nucleosome, where one side needs to be longer than 15 base pairs. Gal4-
VP16 activator can also augment nucleosome acetylation up to 5-fold. However, contrary to our 
expectations, this stimulation does not appear to occur by stabilizing the binding of SAGA toward 
nucleosomes containing an activator binding site. Instead, stimulation of nucleosome acetylation 
occurs by increasing acetylation turnover by SAGA. Altogether, these studies uncover several 
novel mechanisms of SAGA regulation by chromatin substrates. 
Introduction 
 The Spt-Ada-Gcn5 acetyltransferase (SAGA) family of transcriptional coactivators are 
large, multi-subunit complexes that are highly conserved across eukaryotic species, from yeast 
to humans (Nagy and Tora 2007). Subunits of SAGA were originally identified as effectors of 
transcription through genetic screens in budding yeast (Fassler and Winston 1988; Berger et al. 
1992), and were later shown to be associated in a complex containing at least 19 different 
proteins subunits (Grant et al. 1997; Lee et al. 2011). In yeast, SAGA has been shown to be 
important for the transcription of the majority of all inducible genes, such as stress response 
genes that account for approximately 10% of the yeast genome (Huisinga and Pugh 2004). In 
higher eukaryotes, SAGA not only regulates genes that are expressed in response to external 
stress, but also those activated by developmental cues (Spedale et al. 2012). Indeed, mice lacking 
45 
 
SAGA perish during embryogenesis (Xu et al. 2000), and defects in SAGA subunits in humans can 
lead to congenital disorders, such as the neurodegenerative condition of spinocerebellar ataxia 
type 7 (McMahon et al. 2005; Palhan et al. 2005). In addition to a role in transcription, SAGA has 
also been shown to be involved in mRNA export (Garcia-Oliver et al. 2012), DNA repair (Ghosh 
and Pugh 2011), and DNA replication (Burgess et al. 2010). 
 One of the major ways that SAGA achieves its function is through its innate histone 
acetyltransferase activity. This catalytic activity resides in the Gcn5 subunit of SAGA, which 
transfers acetyl groups from acetyl coenzyme A (CoA) to lysine residues in the tails of histone 
proteins (Brownell et al. 1996). Heterologously expressed Gcn5 acetylates a single lysine residue, 
K14, on free histone H3 (Kuo et al. 1996). However, when associated with the other SAGA 
subunits, Gcn5 gains additional specificity and acetylates four primary lysine residues on free and 
nucleosomal H3, and to a smaller degree H2B (Grant et al. 1997; Grant et al. 1999). During 
transcription, this histone acetylation generates transcriptionally activated chromatin, and in 
yeast, SAGA mediates this acetylation in several different ways. Under rich medium conditions, 
SAGA maintains a basal state of histone acetylation globally throughout the yeast genome, 
poising genes for activation (Katan-Khaykovich and Struhl 2002). Under stress conditions, SAGA 
becomes localized to the promoters of induced genes and acetylates chromatin to facilitate 
transcription initiation (Eberharter and Becker 2002). Additionally, for all transcribed genes, 
SAGA is present in the open reading frames of genes, and histone acetylation assists in 
transcriptional elongation (Govind et al. 2007).  
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 How the localization and activity of SAGA is regulated is key to its biological function, and 
a number of factors have been identified, including the incorporation of histones into 
nucleosomes (Balasubramanian et al. 2002), post-translational histone modifications (Lo et al. 
2000; Hassan et al. 2002; Bian et al. 2011), and SAGA-interacting chromatin-associated proteins 
(Sermwittayawong and Tan 2006; Laprade et al. 2007; Sanz et al. 2016). An important class of 
SAGA-interacting chromatin-associated proteins are transcriptional activators (Brown et al. 
2001). These proteins are downstream of signaling pathways and bind to promoter regions of 
induced genes to initiate transcription. In addition to a DNA-binding domain, they contain a 
transcriptional activation domain that can interact with a number of transcriptional coactivators 
and general transcription factors (Kobayashi et al. 1995; Neely et al. 1999; Vojnic et al. 2011). 
Yeast SAGA has been shown to directly interact with numerous different transcriptional activator 
proteins (Brown et al. 2001), and this interaction stimulates nucleosome acetylation, both in vivo 
and in vitro (Kuo et al. 2000; Vignali et al. 2000; Bhaumik and Green 2001). 
 In order to ultimately better understand the requirements and mechanism of activator-
mediated stimulation of SAGA acetylation, we previously developed a nucleosome acetylation 
assay that utilizes chromatin model systems assembled from individual nucleosomes and purified 
endogenous SAGA complex from budding yeast (Mittal et al. 2014). In the course of developing 
this assay, we obtained results suggesting that the DNA flanking a nucleosome could stimulate 
SAGA activity. To substantiate these results, as well as to characterize the effect of activator 
proteins, here we develop several new assays for characterizing nucleosome acetylation and 
binding and apply them to study the role of flanking DNA and activator.  
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Results 
SAGA-mediated nucleosome acetylation 
To characterize how different factors affect the mechanism of SAGA-mediated 
nucleosome acetylation, we developed a bead-based, initial rate, steady state nucleosome 
acetylation assay that extends our previously described acetylation sequencing assay (Mittal et 
al. 2014). In our new assay, we immobilized biotinylated nucleosome GBY (Figure 1A) onto 
streptavidin-coated magnetic beads. GBY was assembled from recombinant histones and a DNA 
template containing 147 base pairs (bp) of the 601 strong octamer positioning sequence that was 
flanked by 95 bp on one side and 15 bp on the other. Embedded in the 95 bp flanking DNA and 
24 bp away from the 147 sequence was the 17 bp recognition sequence for the yeast Gal4 
transcriptional activator domain (Giniger et al. 1985), although no activator protein was present 
in our initial assays. To perform the initial rate, steady state assays, tritium labeled acetyl CoA 
and purified native yeast SAGA complex were added to the bead-bound GBY nucleosomes, and 
aliquots of the reaction were removed at specific time points (Figure 1A). These aliquots were 
washed to remove unincorporated acetyl CoA and then counted by liquid scintillation.  
 These assays included concentrations of SAGA and nucleosomes that were significantly 
lower than we used previously (Mittal et al. 2014) and required optimization to obtain greater 
sensitivity. Therefore, prior to counting samples by liquid scintillation, aliquots were washed with 
hydroxylamine to remove unincorporated acetyl CoA. This compound cleaves the thioester bond 
of acetyl CoA and thereby liberates the tritiated acetyl group away from any CoA non-specifically 
associated with the beads. Using this strategy, we found that linear rates of acetylation could be 
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collected over a wide range of nucleosome concentrations, indicating that steady-state, initial 
rate kinetic analysis was possible. By plotting the initial rates of nucleosome acetylation as a 
function of nucleosome concentration (Figure 1B), we observed saturation of acetylation activity 
on GBY nucleosomes that was well fit to the Michaelis-Menten equation, yielding a KM of 22 ± 4 
nM and a kcat of 1.0 ± 0.1 min-1.  
 Additional experiments were next performed to interpret these kinetic constants. Though 
the KM of an enzyme is often used as a shorthand for the dissociation constant, KD, for its 
substrate, there can be significant deviation between the two. Formally, the KM represents the 
overall dissociation constant of all enzyme-bound species, and can differ from the KD because of 
additional bound intermediates or rapid turnover. To determine the KD of SAGA for GBY 
nucleosomes, a binding titration was performed between SAGA and the GBY nucleosomes in the 
presence of CoA via electrophoretic mobility shift assays (EMSA) (Figure 1C). CoA was used in this 
assay because acetyl CoA would result in turnover by the enzyme, potentially obfuscating our 
analysis of shifted nucleosome. In this experiment, the band corresponding to GBY nucleosome 
alone (left lane) decreases with increasing amounts of SAGA complex, concomitant with the 
appearance of a species with decreased mobility. The shifted species requires SAGA, but is not 
SAGA alone as the DNA stain does not detect SAGA without nucleosomes (Figure 2C, right-most 
lane). These results indicate formation of a complex between SAGA and the nucleosome, and 
give a qualitative measurement of the strength of the interaction, where half-saturation of 
binding appears to occur near 13 nM. An apparent KD of 13 nM is in rough agreement with the 
49 
 
measured KM of 22 nM, although it may reflect an increase in binding affinity between GBY 
nucleosome and SAGA. 
 To better understand the nature of the acetylation turnover parameter, kcat, time course 
experiments were done to probe early and late acetylation events. Initial experiments were 
performed with 200 nM nucleosome (~10 x KM) at a concentration of SAGA complex close to 
nucleosome concentration (50 nM). Under these conditions, acetylation did not proceed with a 
simple linear or exponential rate (Figure 1D). In the late time points, each nucleosome has been 
acetylated on average more than twice (for example, at 300 seconds each nucleosome has ten 
acetylation on average).  This indicates that this portion of the progress curve included kinetic 
information on acetylation subsequent to the first histone acetylation. The rate in this region was 
significantly less than the rate of early time points, and one possible interpretation of this data is 
that after completing the first histone acetylation, subsequent acetylation is significantly slower. 
However, the rate of acetylation in the early time points is significantly greater than the 
measured steady-state turnover from the earlier experiment (Figure 1B), suggesting that the rate 
of acetylation prior to achieving steady-state turnover might be contributing to this difference. 
To investigate this possibility, time course experiments were repeated with less SAGA (4.5 nM), 
where acetylation of the first nucleosomal lysine would not proceed to completion. Under these 
conditions (Figure 1E), as expected, nucleosome acetylation only proceeds to a limited extent (on 
average, only 4% of nucleosomes contained a single acetylation). However, the initial rates of 
acetylation still appear faster than the linear steady-state rate observed later in the time course, 
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and are consistent with burst phase kinetics. Thus, these data together suggest that rapid 
acetylation proceeds steady-state acetylation turnover. 
Effect of flanking DNA 
To probe the effect of flanking DNA on nucleosome acetylation, we compared the GBY 
nucleosome (+95/+15) to a 147 bp nucleosome (+0/+0). This nucleosome is comprised of the 
same recombinant histone proteins and 147 bp of the 601 strong positioning sequence as the 
GBY nucleosome with no flanking DNA. We found that in the absence of flanking DNA, the overall 
rate of nucleosome acetylation was reduced more than 5-fold (Figure 2A), suggesting that 
flanking DNA stimulates nucleosome acetylation. Although our previous studies with GBY 
nucleosomes were not affected by attachment to the bead (Mittal et al. 2014), we compared  the 
rate of acetylation on bead bound 147 bp nucleosomes to those free in solution to ensure this 
attachment was not responsible for the decreased activity (Figure 2A). Attachment of the 147 bp 
nucleosome to the bead did not decrease the extent of its acetylation, confirming that reduction 
in 147 bp nucleosome acetylation relative to GBY nucleosome was due to its lack of flanking DNA. 
 To characterize the mechanism by which flanking DNA stimulated nucleosome 
acetylation, we performed initial rate, steady state kinetic analysis on the 147 bp nucleosome 
and compared the results to that for the GBY nucleosome (Figure 2B). We found that without the 
flanking DNA, the rate of acetylation was lower at all nucleosome concentrations. Under 
saturating nucleosome concentrations, the rate of acetylation decreased 4-fold, corresponding 
to an equivalent decrease in kcat. Additionally, for the 147 bp nucleosome, the half-saturation of 
this activity required a greater nucleosome concentration, corresponding to an increase in KM of 
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2.3-fold. Thus, flanking DNA appears to stimulate nucleosome acetylation in two different ways, 
both by changing the KM and kcat for the reaction, resulting in a 9.20-fold change of the selectivity 
constant of the reaction (kcat/KM). 
 To characterize the meaning of the KM change, we again performed an EMSA experiment 
(Figure 2C). In comparing the GBY and the 147 bp nucleosome, we found that the 147 bp 
nucleosome had a reduced apparent affinity for SAGA, requiring roughly four times the SAGA 
concentration to obtain the same degree of gel shift. Thus, this result supports the idea that 
underlying the ability of flanking DNA to change the KM of SAGA-mediated acetylation is an 
increased binding affinity for such nucleosomes, although the effect of flanking DNA on SAGA 
binding may be larger than its effect on the overall KM of the reaction. 
 To help characterize the observed kcat change, we performed an acetylation time course 
on the 147 bp nucleosome under near-saturating concentrations of nucleosomes (Figure 2D). 
Like the GBY nucleosome, the 147 bp nucleosome exhibits a rapid rise in nucleosome acetylation 
followed by a slower, linear steady state phase. However, both phases are significantly slower 
than those exhibited for the GBY nucleosome. Specifically, it appears that the rate of SAGA on 
the 147 bp nucleosome is 4.12-times slower than the GBY nucleosome at all time points, within 
the error of our measurements (Figure 2E). This is in good agreement with the difference in kcat 
values obtained above (Figure 2B), where the kcat value of the GBY nucleosome was 4-fold faster 
than that for the 147 bp nucleosome, and suggests that the flanking DNA stimulates multiple 
phases of nucleosome acetylation.  
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 To determine which features of the flanking DNA stimulate SAGA-mediated acetylation, 
several different factors were investigated. To probe whether the DNA sequence or which side 
of the nucleosome the DNA flanked were crucial, a GBY-like nucleosome was assembled such 
that the Gal4 consensus sequence was eliminated and the flanking DNA orientation relative to 
the bead was flipped (+15/+95). The acetylation rate was then measured at a non-saturating 
nucleosome concentration (20 nM), so that changes in either KM and/or kcat would be detected. 
The rate of acetylation of this nucleosome was slightly (1.3-fold) higher than that of the GBY 
nucleosome (Figure 3A), indicating, at most, a modest role of sequence or nucleosome side in 
controlling acetylation rate.  
 To address how the length of the flanking DNA affected acetylation, we assembled and 
characterized nucleosomal substrates that had flanking DNA of various lengths on a single side 
of the nucleosome (Figure 3B). We observed that this flanking DNA could stimulate acetylation 
activity, but to a lesser extent than the original GBY nucleosomes. Because our test nucleosomes 
did not contain flanking DNA on both sides, while the GBY nucleosome had at least 15 bp on both 
sides, we tested a nucleosome containing 15 bp on either side (+15/+15) (Figure 3C). While this 
nucleosome did show acetylation activity greater than the 147 bp nucleosome, it was still 
significantly less than observed for the GBY nucleosome. However, in testing a nucleosome with 
80 bp of flanking DNA on both sides (+80/+80), activation greater than the single sided 80 bp 
(+0/+80) nucleosome was observed (compare 3B and 3C), and the level of activation was 
comparable to that of the GBY nucleosome. Thus, these experiments suggest that full stimulation 
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of SAGA-mediated nucleosome acetylation requires flanking DNA on both sides of the 
nucleosome, with one side requiring more than 15 bps of flanking DNA. 
Effect of activator protein 
Because transcriptional activator proteins are known to interact with SAGA and facilitate 
targeted nucleosome acetylation (Kuo et al. 2000; Bhaumik and Green 2001), we sought to 
quantify the magnitude and mechanism by which activators facilitate acetylation. For our studies, 
the fusion protein Gal4-VP16 was chosen as it is one of the best characterized activator protein 
systems and has been used extensively in studies of SAGA activity in vivo and in vitro (Berger et 
al. 1992; Vignali et al. 2000).  Its interactions with other coactivators and general transcription 
factor complexes have also been well studied (Kobayashi et al. 1995; Neely et al. 1999; Vojnic et 
al. 2011). This protein contains the DNA binding domain of the yeast Gal4 activator and the 
activator domain of the herpes simplex virus protein, VP16 (Sadowski et al. 1988; Triezenberg 
1995). 
 Gal4-VP16 has been shown to bind to its consensus sequence with high affinity (Parthun 
and Jaehning 1990). Our EMSA experiments confirm these previous results. Utilizing recombinant 
Gal4-VP16 and the GBY DNA template used to make GBY nucleosomes (Figure 1A), we showed 
that increasing amounts of activator protein resulted in formation of a shifted species with 
concomitant reduction of the free DNA (Figure 4A).  
 Since these experiments indicate that the DNA binding domain of the Gal4-VP16 is 
functional, we characterized to what extent the activator domain of Gal4-VP16 could stimulate 
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acetylation. For these experiments, increasing amounts of Gal4-VP16 were titrated into reactions 
containing 20 nM GBY nucleosome and 2.5 nM SAGA (Figure 4B). Nucleosome concentration was 
chosen to be non-saturating, so that potential stimulation of acetylation activity due to either 
changes in KM and/or kcat would be observable. Indeed, strong activator-dependent stimulation 
of the acetylation rate was observed, which was especially apparent in comparing rates for high 
concentrations of activator (Figure 4B, right points) versus those lacking activator (Figure 4B, 
leftmost point). Further, activator stimulation increased in a manner expected for saturation 
binding. At lower concentrations of Gal4-VP16, activator was sub-stoichiometric relative to 
nucleosomes, and stimulation was not complete. With more Gal4-VP16, stimulation increased 
up to a point. The observed plateau of stimulation at higher concentrations of activator, despite 
a stoichiometric excess of activator to nucleosome, presumably occurs because all Gal4 binding 
sites in the GBY nucleosomes are saturated.  
 The observed stimulation appears to depend on Gal4-VP16 binding to the Gal4 DNA 
binding site (Figure 4C, left). Unlike the case with Gal4-VP16, addition of increasing amounts of 
BSA does not increase nucleosome acetylation (Figure 4C, middle), suggesting that stimulation is 
not simply due to non-specific effects of protein addition. Further, when increasing amounts of 
Gal4-VP16 are added to the 147 bp nucleosome, which lacks the Gal4 binding site, there is a 
significantly more modest stimulation of acetylation that does not reach the stimulation 
observed with the GBY nucleosome, even at significantly higher concentrations of activator 
protein (Figure 4C, right). These data suggest that Gal4-VP16 by itself is less efficient in 
stimulating nucleosome acetylation if its DNA binding site is not present. 
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 To dissect how Gal4-VP16 mechanistically stimulates acetylation activity, we performed 
initial rate, steady state nucleosome acetylation assays with varying concentrations of GBY 
nucleosome in the presence of a 2:1 ratio of activator:nucleosome (Figure 4D). Our expectation 
had been that the activator would stabilize SAGA binding to nucleosomes, reducing the 
concentration of nucleosome required for half-saturation of acetylation activity (KM) without 
changing SAGA acetylation activity when fully saturated with nucleosome (kcat). However, that 
was clearly not the case. The presence of activator increased kcat by 4.8-fold (Figure 4C). 
Additionally, KM in the presence of activator was not decreased, but increased from 22 ± 4 nM to 
46 ± 11 nM. Thus, our data suggests that activator works predominantly not by increasing the 
affinity of SAGA for nucleosome, but by stimulating the turnover rate of acetylation. 
 To more directly probe the effect of activator on the binding of SAGA to nucleosome, 
EMSA experiments were performed on GBY nucleosomes with increasing amounts of SAGA, 
either with or without Gal4-VP16 (Figure 4E). Unlike the case in which 147 bp nucleosomes 
changed the concentration of SAGA necessary to generate shifted species (Figure 2C), the shifts 
with activator are not significantly different from those without. These data indicate that 
activator does not significantly increase the affinity constant of SAGA for nucleosome, consistent 
with the steady state results.  
 To better characterize the source of the kcat change, time course experiments with 
activator protein were performed with saturating concentration of nucleosomes. Direct 
comparison of the time courses for GBY nucleosome acetylation with and without Gal4-VP16 
revealed that the presence of activator strongly augmented acetylation throughout the time 
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course (Figure 4F). As expected from our steady state experiments, this increase included the 
later time points, corresponding to the steady state phase of the reaction. This change was also 
observed in the early time points corresponding to the pre-steady state phase. To a first 
approximation, this stimulation was relatively uniform throughout the time course, meaning that 
the activator largely affected the amplitude, but not its shape. As with the case for the time 
course of nucleosomes with and without flanking DNA (Figure 2E). That said, our data does show 
some differences in the shape of the time course in the steady state region, where there appears 
to be a slight increase in the rate of acetylation. Nonetheless, even if present, the effect appears 
to be relatively modest. 
Discussion 
In this study, we have utilized nucleosome binding and acetylation assays to characterize 
how features of the environment surrounding nucleosomes affect acetylation. We find that both 
DNA flanking the nucleosome (+95/+15) and the presence of activator proteins significantly 
stimulate the rate of nucleosome acetylation, with each factor capable of increasing the rate of 
acetylation by 5-fold or more. We have mapped some of the basic requirements for this 
stimulation. For the flanking DNA, DNA on both sides of the nucleosome are needed for full 
stimulation, but full stimulation was not observed in the +15/+15 nucleosome. Thus, one side 
needs to more than 15 bp in length, while the other side can be 15 bp or less. For the activator, 
the identity of the protein is important, as not just any protein can increase the rate of 
acetylation. Additionally, the presence of the activator binding site DNA is also needed to observe 
full stimulation by the activator.  
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 Further kinetic analysis has allowed us to dissect mechanistic aspects of acetylation 
stimulation, and we observe two distinct mechanisms that contribute to a varying degree. One 
contributor is changes in SAGA affinity for nucleosome. DNA flanking the nucleosome reduced 
the concentration of nucleosome necessary to achieve half-saturation of acetylation activity. 
Moreover, direct characterization of SAGA binding to nucleosome show that the flanking DNA 
increases SAGA binding affinity. In contrast, there does not appear to be a significant role of 
increased SAGA binding in activator-mediated stimulation, as neither the steady-state kinetic 
measurements, nor the direct nucleosome binding assays, demonstrate improved SAGA binding 
in the presence of activator.  
 The other mechanism contributing to acetylation stimulation is an increase in the 
maximal steady-state rate of acetylation, and both flanking DNA and activator protein act 
through this mechanism. Further analysis shows that acetylation proceeds at distinct rates during 
different stages of the reaction, and that flanking DNA and activator stimulates the rate of 
acetylation at all stages. These stages include events after the first acetylation and before the 
first enzymatic turnover, where acetylation appears to proceed through a burst phase. It is 
possible that the observed changes in rates could simply be due to flanking DNA and activator 
increasing the affinity of SAGA for acetyl CoA, such that stimulation would disappear with 
saturation of acetyl CoA binding. However, this does not appear to be the case, as the extent of 
stimulation remains unchanged at high concentrations of acetyl CoA (10x of KM, data not shown).  
 The observation of burst phase kinetics suggests potential mechanisms by which 
acetylation proceeds. In the basic model of burst-phase kinetics, the chemical step is fast relative 
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to subsequent steps. This results in an initial burst of product, because the first time an enzyme 
acts it does so rapidly. However, to perform subsequent reactions, the enzyme has to proceed 
through the subsequent rate limiting step, and consequently the steady-state rate reflects the 
slower, rate-limiting step. A common way that this can occurs is though generation of a covalent 
intermediate during the reaction. This occurs, for example, in some proteases; a covalent adduct 
is formed between part of the peptide and the enzyme with rapid release of the other half of the 
peptide.  At a much slower rate, a water molecule hydrolyzes the covalent enzyme-peptide 
intermediate, thereby releasing the peptide and enabling the enzyme to perform another 
catalytic cycle. Nucleosome acetylation could go through a covalent enzyme intermediate, where 
an acetyl group is transferred from acetyl CoA to SAGA prior to transfer of the acetyl group to 
the histone. However, prior studies with the catalytic Gcn5 subunit show that no covalent 
intermediate is formed (Tanner et al. 2000). Further, our assay specifically monitors generation 
of histone acetylation, not release of CoA, and does not retain SAGA on the beads (data not 
shown). Thus, it is unlikely that the observed burst-phase kinetics are due to a covalent enzyme 
intermediate. 
 Another common mechanism for burst phase kinetics is that product release is slow 
relative to product generation. In this case, when product formation is monitored, there is a burst 
of product prior to the first turnover, with slower steady-state kinetics for subsequent turnovers. 
Our data is consistent with such a model where SAGA acetylation of the H3 histone could be 
relatively rapid, but the tight interactions of many subunits of SAGA with multiple parts of the 
nucleosome results in slow release of the acetylated nucleosome. This model is made more 
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complicated by two additional factors. Because multiple sites of acetylation are available within 
the H3 histone and the nucleosome in general, this burst phase might additionally represent 
multiple histone acetylations prior to slow nucleosome release (Grant et al. 1999; 
Balasubramanian et al. 2002). Also, because SAGA contains bromodomains that can bind 
acetylated histones, generation of nucleosome acetylation might itself promote SAGA retention, 
further slowing product release (Dhalluin et al. 1999; Hassan et al. 2007). It should be noted that 
release and preferential rebinding of acetylated nucleosomes might mimic nucleosome 
acetylation without release. However, a published study is consistent with committed binding 
between multiple nucleosome acetylations (Ringel et al. 2015), and thus we interpret the burst 
phase kinetics observed to being due to multiple acetylations prior to nucleosome release. Such 
a model (Figure 5) provides a potential interpretation of how flanking DNA and activator can 
affect both the burst phase and steady-state phase of the reaction. If these factors facilitate more 
acetylation per turnover without changing the release rate, increased acetylation would be 
observed both in the burst-phase first turnover, as well as higher levels of acetylation per 
turnover, in the steady-state phase. How binding of DNA or activator increase acetylation per 
turnover is not clear, but could occur through allosterically induced changes to the catalytic site. 
  The ability of DNA flanking the nucleosome to stimulate SAGA activity is not unique to 
this coactivator complex. ATP-dependent chromatin remodeling complexes have been shown to 
be influenced by nucleosome flanking DNA. For example, the chromatin-assembly factor (ACF) 
complex spaces nucleosomes evenly on DNA by increasing its remodeling activity in response to 
longer flanking DNA (Yang et al. 2006). Additionally, the SWI/SNF-related (SWR1) complex 
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incorporates the non-canonical histone H2A.Z/H2B dimer into the chromatin near nucleosome-
free regions of DNA by preferentially binding and remodeling nucleosomes with flanking DNA 
(Ranjan et al. 2013). These examples demonstrate that flanking DNA is integral in the biological 
role of these chromatin remodeling complexes. Our results with SAGA suggest that the ability of 
the flanking DNA to change the localization and activity of chromatin remodeling complexes 
extends to those which modify histones, as well. Stimulation of SAGA binding and acetylation 
activity towards nucleosomes possessing substantial flanking DNA may also contribute to its 
overall biological activity. The amount of flanking DNA surrounding a nucleosome varies 
throughout the genome. However, in budding yeast, the most common DNA distance between 
nucleosomes is 15 base-pairs (Brogaard et al. 2012), suggesting that many nucleosomes would 
have less flanking DNA on both sides necessary for full SAGA activity. Further, nucleosome 
positioning can be dynamic, where nucleosome density can decrease during transcription (Adkins 
et al. 2007), and this could help facilitate SAGA action. For example, the SAGA complex is found 
at all open reading frames all transcribed genes (Govind et al. 2007). As transcription occurs and 
nucleosome density decreases, SAGA might preferentially bind in these regions, acetylate 
nucleosomes, and promote downstream transcriptional events. 
 As the acetylation activity of SAGA is sensitive to flanking DNA, it is likely that subunits of 
SAGA directly bind to flanking DNA. Putative DNA binding domains within subunits of SAGA have 
been identified, and may serve this role. The Swi3/Rsc9/Moira (SWIRM) domain of mouse Ada2α, 
a subunit required for the expanded specificity of Gcn5 (Balasubramanian et al. 2002), was shown 
to bind double stranded DNA and a dinucleosome substrate with approximately 165 bp of linker 
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DNA, but does not bind a single nucleosome that lacked flanking DNA (Qian et al. 2005). Our 
activity results correspond with this observation, as SAGA demonstrates higher affinity and 
activity on nucleosomes containing flanking DNA versus none. The zinc finger domain of Sgf11 is 
another putative DNA binding domain in SAGA. Sgf11 associates with Ubp8, a subunit which 
performs the second catalytic activity of SAGA, the deubiquitination of histone H2B (Kohler et al. 
2010; Samara et al. 2010). NMR titration experiments demonstrate that the zinc finger domain 
can weakly bind double stranded DNA, but strongly bind nucleosomes (Koehler et al. 2014). 
However, this tight binding of nucleosomes may not result from DNA binding but from interaction 
of the domain with the acidic patch on the H2A/H2B dimer (Morgan et al. 2016). Further, both 
fission yeast and human TFIID has been shown to make interactions with the DNA beyond TATA-
binding protein (TBP) interactions (Elmlund et al. 2009; Cianfrocco et al. 2013). SAGA shares a 
core of TBP-associated factors (TAFs) with TFIID that act as a scaffold for assembly of other 
proteins, some of which may also interact with the DNA (Bieniossek et al. 2013; Han et al. 2014). 
 Transcriptional activators bind to DNA consensus sequences and interact with 
coactivators and basal transcription factors to promote formation of the pre-initiation complex 
at promoters (Weake and Workman 2010). SAGA has been shown to directly interact with a wide 
range of transcriptional activators (Brown et al. 2001), and the transcriptional activation domain 
of VP16 has been shown to interact with a number of SAGA subunits in isolation, including Ada2 
(Silverman et al. 1994; Barlev et al. 1995), Taf9 (Uesugi et al. 1997; Nedialkov and Triezenberg 
2004), and Tra1 (Brown et al. 2001). However, crosslinking experiments with the full SAGA 
complex indicate that VP16 interaction occurs predominantly with the Tra1 subunit (Brown et al. 
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2001). The interaction of SAGA with activator results in localized nucleosome hyperacetylation in 
vivo at gene promoters, and in vitro in reconstituted chromatin model systems (Kuo et al. 2000; 
Vignali et al. 2000). Based on the ability of activators to bind coactivators and general 
transcription factors (Kobayashi et al. 1995; Neely et al. 1999; Vojnic et al. 2011), the model 
generally proposed for activator function is that it recruits factors to the promoter. Indeed, in 
probing the source of activator-stimulated nucleosome acetylation (Figure 4B), we expected that 
Gal4-VP16 would increase the affinity of SAGA for nucleosomes. On the contrary, our steady state 
kinetic analysis of the saturation of acetylation activity (Figure 4D) and direct characterization of 
nucleosome binding by SAGA (Figure 4E) both indicate that activator does not increase binding 
affinity. Instead, activator appears to increase the overall acetylation turnover. Thus, our data 
suggests that at promoters, interaction of SAGA with activators does not act so much as to recruit 
SAGA, but instead locally stimulates its acetylation activity.  
 This finding represents a novel mechanism of activator actions with respect to SAGA, and 
potentially for activator-interacting proteins in general. While it is not clear how interactions 
between Gal4-VP16 and SAGA produce this stimulation, based on the distance between the 
VP16-interacting subunit, Tra1, and the catalytic subunit, Gcn5 (Wu et al. 2004; Han et al. 2014), 
as mentioned above, it is possible that activator binding allosterically changes Gcn5 activity via 
some conformational change. Such allosteric activation by proteins is a common regulatory 
strategy, and even in the absence of activator there is evidence from electron microscopy and 
crosslinking studies that SAGA, or SAGA missing specific subunits, can adopt different 
conformations (Durand et al. 2014; Nguyen-Huynh et al. 2015; Setiaputra et al. 2015). 
63 
 
Additionally, the ability of activator proteins to induce conformational changes in binding 
partners has precedence. For example, the Rap1 activator protein can induce conformational 
changes in the basal transcription factor complex TFIIA (Papai et al. 2010), and various activators, 
including VP16, can induce conformational changes in the CRSP coactivator complex (Taatjes et 
al. 2002; Tsai et al. 2014). 
Experimental procedures 
Nucleosome preparation  
Biotinylated GBY DNA was prepared as described previously (Mittal et al. 2014). All 
other DNA for nucleosome assembly were generated by PCR amplification using a forward 
primer containing a biotin moiety with a 15 atom spacer at the 5’ end, with sequences in the 
supplementary materials. Recombinant Xenopus laevis histones were prepared (Luger et al. 
1999a) and assembled into octamers (Luger et al. 1999b), as previously described. Nucleosomes 
were assembled by depositing the histone octamer on different lengths of template DNAs by 
the process of rapid dilution and then dialysis into LDB buffer (2.5 mM NaCl, 10 mM Tris pH 7.4, 
0.25 mM EDTA), as described previously (Blacketer et al. 2010). The homogeneity and degree of 
saturation of the assembled nucleosomes were assessed on a 4% Native PAGE. GBY 
nucleosome was immobilized on hydrophilic streptavidin beads from New England Biolabs, as 
described previously (Mittal et al. 2014). Other nucleosomes containing biotinylated DNA were 
directly bound to the streptavidin beads by incubating approximately 200 g resin with 3.73 
pmol mg/nmoles nucleosome at a final concentration of 150 nM.  
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SAGA and Gal4VP16 preparation 
 Endogenous SAGA complex from Saccharomyces cerevisiae was purified using the TAP 
purification strategy, as previously (Wu and Winston 2002). The purity of the complex was 
confirmed by silver stain gel analysis. The purified enzyme was quantitated by Western Blot in 
comparison to known amounts of recombinantly expressed and purified Gcn5 that had been 
quantified by Bradford Analysis, and SAGA stocks were typically prepared at a concentration 
between 80 – 150 nM. Activity of the purified enzyme was assessed with a synthetic H3 peptide, 
as previously described (Li and Shogren-Knaak 2008). Recombinant Gal4VP16 was purified from 
E.coli Xa90 cells transformed with pJL2S plasmid (a generous gift from Dr. Steve Treizenberg) 
largely according to a previously published protocol (Dechassa et al. 2008).  
Electrophoretic mobility shift assays 
Binding between 2 nM GBY DNA and Gal4-VP16 (0, 2, 4, 8, 16 and 32 nM) was performed 
at RT for 15 minutes in 20 l of binding buffer (10 mM HEPES, 100 mM NaCl, 5 mM DTT, 4 mM 
MgCl2.6H2O, 1 mM PMSF, 5% glycerol; pH 7.5). Reaction products were resolved by 4% Native 
PAGE, at 60V for 60 minutes in 0.5X TBE. Binding between 5 nM GBY or 147 bp nucleosomes and 
SAGA (0, 7, 13, 27, and 53 nM) was performed at 30° C for 9 minutes in 7 l reaction. 5 nM 
nucleosomes were pre-incubated with 30 M CoA at 30° C, with or without 20 nM Gal4-VP16. 
Reaction products were resolved on a pre-run (30 minutes at 100 V at 4ᵒC) composite gel (0.25% 
agarose and 2% acrylamide). The gel was run for 25 minutes at 100 V at 4ᵒC in 0.25X TBE. Gels 
were stained with SYBR Gold stain. All EMSA experiments were performed at least two times. 
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Acetylation kinetics 
Steady state kinetics were performed under initial rate conditions, with limiting 
concentrations of SAGA (Mittal et al. 2014). Generally, 25 μL of bead bound substrate at 2X of 
the desired final nucleosome concentration in LDB was mixed with 25 μL of 2X HAT buffer (50 
mM Tris pH 7.5, 10% glycerol, 0.25 mM EDTA, 300 mM NaCl, 2 mM DTT, 2 mM PMSF, 20 mM 
sodium butyrate, 8 μM acetyl CoA, with a specific activity of tritiated acetyl CoA of 15.6 - 37.0 
Ci/mmol). After incubated at 30°C for 5 minutes, reactions were initiated by adding 1 L of SAGA 
stock (1.25-2.5 nM final enzyme). 10 μL aliquots were taken at 0’, 3’, 6’, and 9’ and were directly 
added to tubes containing 10 μL of WB1 (100 mM NaCl, 50 mM Tris-Cl, 10 mM MgCl2, 1 mM DTT, 
0.1% Triton X-100). Each sample was washed 4 times with WB1 at RT and five times with WB2 
(50 mM NH2OH, 0.1% Triton X-100, 50 mM Tris-Cl; pH 7.5) at 37°C, with 25 minutes of incubation. 
The beads were resuspended in 10 L of WB1 and 6-9 mL of EcoScint scintillation cocktail. 
Acetylation generated per time was determined from the CPM by accounting for the specific 
activity of the labeled CoA, the instrument counting efficiency, counting efficiency of bead bound 
or solution substrate (same), reaction aliquot volume, CPM to DPM to Ci conversion. Rates were 
fit to the Michaelis-Menten equation to get half-saturation and turn-over parameters. Bead-free 
acetylation assays were performed as described previously (Mittal et al. 2014). In all kinetic 
experiment, each condition was repeated at least three times. 
 Assays with a fixed concentration of nucleosome and increasing amounts of activator 
were performed as described in the preceding paragraph, but with 20 nM of either GBY or 147 
nucleosome and varying concentrations of Gal4-VP16 or BSA (0-800 nM). Data for increasing 
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amounts of Gal4-VP16 with GBY nucleosome were fit to a quadratic form (Pollard 2010), to 
account for the fact that the concentration of activator was potentially close to its KD. For assays 
with increasing concentration of nucleosome, Gal4-VP16 was added to 2x the nucleosome, but 
otherwise performed as described in the previous paragraph. 
 Experiments focused on characterizing the time course of more extensive acetylation 
were performed as above with either 4.5 nM or 50 nM SAGA and 200 nM nucleosome as above, 
but with an unlabeled acetyl CoA reaction quench step. Specifically, 10 l reactions were stopped 
with addition of 10 l of 250 M cold acetyl CoA in WB1. In reactions containing Gal4-VP16 
reactions, 2X activator:GBY nucleosome was used. To fit a mechanism-free model of acetylation 
progression (Sassa et al. 2013), acetylation incorporation was fit to the sum of a linear and simple 
exponential component. For a mechanism-based model of burst phase kinetics, an analytically 
derived fit was utilized (Fersht 1999). To account for the possibility of multiple acetylations per 
enzyme turnover in the burst phase, the acetylations/turnover was included as a fit parameter. 
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Figures 
 
 
 
Figure 1. Characterization of SAGA nucleosome acetylation activity. (A) Schematic of the bead-
bound GBY nucleosome and the steady state nucleosome acetylation assay. Gal4 refers to the 
position of a Gal4 binding site, although initial assays were not performed with activator 
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proteins. (B) Steady state kinetics of GBY nucleosome acetylation. Initial rates of SAGA-
mediated nucleosome acetylation were plotted at varying GBY nucleosome concentrations and 
data were fit to the Michaelis-Menten equation. Error bars here and throughout represent the 
standard deviation of at least three trials. (C) SAGA complex binds GBY nucleosomes with a high 
apparent affinity. EMSA with GBY nucleosomes and increasing amounts of SAGA complex. (D) 
Time course of SAGA-mediated nucleosome acetylation under saturating nucleosome binding 
conditions with near-stoichiometric amounts of SAGA. Time point data were fit to the sum of 
an exponential and linear component. To accentuate the difference between the early and late 
acetylation kinetics, a linear fit to later portion of the time course is shown extrapolated to time 
zero. (E) Time course of SAGA-mediated nucleosome acetylation under saturating nucleosome 
binding conditions with limiting amounts of SAGA. Data and fitting are treated similarly to part 
D. 
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Figure 2. Effect of flanking DNA on SAGA activity. (A) Flanking DNA in the GBY nucleosome 
stimulates nucleosome acetylation activity. The extent of acetylation was measured for a bead-
bound GBY nucleosome, a bead-bound 147 bp nucleosome lacking flanking DNA, and a 147 bp 
nucleosome free in solution. (B) Steady state nucleosome acetylation analysis shows that the 147 
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bp nucleosome (white circles) has both an altered KM and kcat relative to the GBY nucleosome 
(black circles). Assays were performed as described in 1B, with data for the GBY nucleosome 
reproduced from 1B for comparison. (C) Lack of flanking DNA reduces the apparent affinity of 
SAGA for nucleosome. EMSA with GBY nucleosome (reproduced for comparison from figure 1C) 
or 147 bp nucleosome, both with increasing amounts of SAGA complex. (D) Lack of flanking DNA 
reduces acetylation turnover both initial and late acetylation. Experiments for the 147 bp 
nucleosomes (white circles) were performed as described for the GBY nucleosomes in 1D, with 
the GBY nucleosome data (black circles) included for comparison. (E) Flanking DNA uniformly 
affects the kinetics of initial and late nucleosome acetylation. Data from 2D is replotted, where 
the scale of the y-axis scale for the 147 bp nucleosome (left axis) is shown at 4.12-fold that of the 
GBY nucleosome (right axis). 
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Figure 3. Mapping of flanking DNA requirements. (A) The sequence and orientation of flanking 
DNA with respect to the nucleosome doesn’t change rate of acetylation. Comparison of SAGA 
nucleosome acetylation activity between the GBY nucleosome (+95/+15) and one in which the 
flanking DNA has been flipped and the sequence randomized (+15/+95). (B) Flanking DNA on one 
side of the nucleosome increases acetylation, but is not sufficient to stimulate full activity. 
Comparison of SAGA nucleosome acetylation activity on GBY nucleosome, 147bp nucleosome 
(+0/+0), and three nucleosomes which contain differing amounts of flanking DNA only on one 
side of the nucleosome (+0/+40, +0/+60, +0/+80). (C) Flanking DNA larger than 15 bp on both 
sides a nucleosome can fully stimulate acetylation. Comparison of SAGA nucleosome acetylation 
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activity on GBY nucleosome, 147bp nucleosome, and two nucleosomes which contain equal 
length of flanking DNA on both sides of the nucleosome (+15/+15, +80/+80).  
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Figure 4. Effect of activator protein on SAGA activity. (A) Recombinant Gal4-VP16 protein binds 
tightly to DNA containing a Gal4 recognition site. EMSA with GBY nucleosome DNA and increasing 
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amounts of Gal4-VP16 protein. (B) Addition of Gal4-VP16 protein stimulates SAGA acetylation 
activity of a GBY nucleosome. The initial rate of nucleosome acetylation was assessed with 
varying concentrations of Gal4-VP16 dimer. The data was fit to a model of activator binding that 
takes into account the fact that Gal4-VP16 dimer was sub-stoichiometric relative to nucleosome 
at low activator concentrations. (C) Gal4-VP16 protein stimulation of acetylation requires Gal4-
VP16 protein and the Gal4 DNA binding site. Comparison of initial acetylation rates for either GBY 
or 147 nucleosomes with increasing amounts of either Gal4-VP16 or Bovine serum albumin. 
Acetylation rates have been normalized so that the rate without added protein is one, and the 
data for the GBY nucleosome with Gal4-VP16 is the same as those shown in part B. (D) Gal4-VP16 
protein stimulates SAGA acetylation activity by increasing kcat. Comparison of the steady state 
turnover (rate/enzyme) of GBY nucleosome acetylation in the presence (grey circles) or absence 
of Gal4-VP16 (black circles). The initial rate assays were performed as in Figure 1B and the data 
without Gal4-VP16 are reproduced for comparison. (E) Addition of Gal4-VP16 protein does not 
significantly change binding of SAGA to a GBY nucleosome. EMSA with GBY nucleosomes with or 
without Gal4-VP16 protein, and with increasing amounts of SAGA. (F) Addition of Gal4-VP16 
stimulates both early and late phases of nucleosome acetylation (grey circles) compared with the 
same conditions without activator (black circles). The y-axis for acetylation turnover in the 
presence of activator (right axis) has been significantly scaled down to directly compare the shape 
of the time course to the similar reaction without activator (left axis). 
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Figure 5. Possible model of nucleosome acetylation with role of flanking DNA and activator 
protein. Nucleosome acetylation proceeds through multiple steps, including nucleosome 
binding, H3 tail acetylation at multiple lysines without nucleosome release, and nucleosome 
release. Potential activating contacts between SAGA, flanking DNA, and activator are depicted 
with asterisks.  
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Abstract 
Eukaryotic gene expression requires the coordination of multiple factors to overcome the 
repressive nature of chromatin. The SAGA family of transcriptional coactivators are recruited to 
gene promoters via interactions with DNA binding activators to establish regions of 
hyperacetylation. We have characterized the components necessary for stimulation of the 
histone acetyltransferase (HAT) activity of SAGA by a transcriptional activator using both kinetics 
assays and binding interactions studies. We find that stimulation of the HAT activity of SAGA 
occurs in cis and requires activator to bind to flanking DNA of the target nucleosome. We also 
observe that activator binds non-specifically to nucleosomes. Both the SAGA and ADA complexes 
can clear this non-specific binding, while the minimal HAT module cannot. Finally, we 
demonstrate that most the stimulation of the HAT activity of SAGA results from interactions of 
the Tra1 subunit with activators. 
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Introduction 
Transcriptional coactivators function directly downstream of sequence-specific DNA 
binding activator proteins to promote eukaryotic gene expression. In general, coactivators are 
large, multi-subunit complexes with multiple functions. Numerous different categories of 
coactivators have been characterized, include coactivators that change the modification state of 
histones, those that alter nucleosome positioning and composition, and those that directly bridge 
activator proteins and the general transcriptional machinery (Wood et al. 2003; Nagy and Tora 
2007; Dechassa et al. 2008; Ranjan et al. 2013; Helmlinger and Tora 2017; Soutourina 2017). 
The SAGA (Spt-Ada-Gcn5 acetyltransferase) complex from budding yeast was one of the 
first discovered histone modifying complexes (Brownell et al. 1996; Grant et al. 1997), and has 
served as a prototype for understanding activator-coactivator function. SAGA is highly conserved 
across eukaryotes and regulates a wide range of inducible genes, including most stress response 
genes in budding yeast and a wide range of stress response and developmental genes in higher 
eukaryotes (Huisinga and Pugh 2004; Spedale et al. 2012). SAGA is a 1.8 MDa complex and is 
composed of 19 subunits that are arranged into four functional modules (Grant et al. 1997; Lee 
et al. 2011). These include the histone acetyltransferase (HAT), deubiquitination (DUB), Spt, and 
Taf modules (Lee et al. 2011).  
The enzymatic modules can be isolated from the complex, and it has been shown that 
subunits within the modules modify the activity of the core catalytic subunits (Grant et al. 1999; 
Balasubramanian et al. 2002; Henry et al. 2003; Daniel et al. 2004). For example, alone, the 
acetyltransferase enzyme Gcn5 can only acetylate a single lysine residue on free histone H3 
(Grant et al. 1999; Balasubramanian et al. 2002). When in a complex with Ada2 and Ada3, the 
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specificity of Gcn5 expands to that of SAGA, acetylating four primary lysine residues on free and 
nucleosomal histone H3 (Balasubramanian et al. 2002). Interestingly, the HAT module of SAGA is 
not limited to the SAGA complex. In additional to other complexes that are largely composed of 
the same components (Pray-Grant et al. 2002), the HAT module of SAGA is also found in 
complexes that differ significantly in their other subunits (Nagy et al. 2010; Riss et al. 2015). In 
budding yeast, this includes the ADA complex, which contains Ahc1 and Ahc2 proteins in 
association with the HAT module (Eberharter et al. 1999; Lee et al. 2011). However, beyond its 
composition and the fact it too can acetylate nucleosomes (Grant et al. 1999; Lee et al. 2011), 
the ADA complex has not been characterized significantly. 
As a coactivator, SAGA stimulates gene expression through its acetyltransferase function 
and via interactions with activator proteins. Under stress or developmental conditions, SAGA 
complexes are localized to gene promoters and establish regions of hyperacetylation (Kuo et al. 
1998; Krebs et al. 1999; Eberharter and Becker 2002). This localization was further shown to be 
dependent on SAGA interacting with DNA-binding activator proteins (Utley et al. 1998; Ikeda et 
al. 1999; Kuo et al. 2000; Vignali et al. 2000). These results are complemented by numerous 
studies demonstrating that many subunits in SAGA interact with activator proteins (Uesugi et al. 
1997; McMahon et al. 1998; Brown et al. 2001; Gamper and Roeder 2008). Thus, these studies 
have led to a model in which activator proteins enhance SAGA-mediated nucleosome acetylation 
by stabilizing binding of SAGA to chromatin associated with activators. 
Recently, our group has investigated the mechanism of Gal4-VP16 activator stimulation 
of SAGA-mediated nucleosome acetylation. This stimulation of HAT activity is due to the increase 
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in the turnover rate of the reaction, not the apparent binding affinity of SAGA to chromatin or 
acetyl coenzyme A (CoA). Here, we further characterize the components required for the 
stimulation of the HAT activity of SAGA by Gal4-VP16 activator, including the binding 
requirements for activator stimulation and mapping of the SAGA subunit most responsible for 
stimulation. Results from these studies revealed novel properties of the HAT module in isolation 
and were then further examined within the context of the ADA complex.  
Results 
Stimulation by activator occurs in cis  
Gal4-VP16 activator was shown to stimulate nucleosome acetylation turnover by SAGA 
(Mittal et al 2018). To characterize how Gal4-VP16 activator interacted with the chromatin 
substrates to stimulate the HAT activity of SAGA, we used a bead-based, steady state nucleosome 
acetylation assays (Mittal et al. 2018). Briefly, endogenously expressed SAGA was purified from 
budding yeast and then incubated with nucleosomes substrates. One substrate, GBY 
nucleosome, possessed flanking DNA on both sides of the nucleosome, and a 17 bp consensus 
sequence for the activator Gal4 was embedded in one side of the flanking DNA. Another 
nucleosome, 147 bp nucleosome, had no flanking DNA. To further characterize the minimal 
requirements for stimulation by activator, we also tested the HAT activity of SAGA on H3 peptides 
in a filter-binding assay. 
To determine if nucleosomal flanking DNA was required for the stimulation by activator, 
we compared the rate of SAGA HAT activity on GBY nucleosomes to substrates lacking flanking 
DNA. The addition of Gal4-VP16 activator to reactions of SAGA and GBY nucleosomes increased 
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the HAT activity as previously seen (Figure 1A, left graph, left; Mittal et al. 2018). In contrast, 
when increasing concentrations of Gal4-VP16 activator were added to reactions of SAGA and 147 
bp nucleosomes, the rate of acetylation was not stimulated (Figure 1A, left graph, right). A similar 
result was observed when Gal4-VP16 activator was added to HAT assays on H3 peptide (Figure 
1A, right graph). These results demonstrate that activator alone is not sufficient to stimulate HAT 
activity, and that DNA-binding is necessary. 
Stimulation of SAGA HAT activity appears to occur in cis. That is, Gal4-VP16 activator binds 
its consensus sequence in flanking DNA of GBY nucleosomes to increase HAT activity. To 
determine if stimulation could also occur in trans, HAT assays were again performed on the 147 
bp nucleosome and H3 peptide substrates, but this time in the presence of the 17 bp Gal4 
consensus DNA and Gal4-VP16 activator. Previously, we, and others, have observed that Gal4 
DNA binding domain binds its consensus sequence with high affinity (Parthun and Jaehning 1990; 
Hong et al. 2008)(Mittal et al. 2018). The inclusion of Gal4-VP16 activator to reactions of SAGA 
and 147 bp nucleosomes with increasing concentrations of Gal4 DNA did not stimulate the HAT 
activity of SAGA (Figure 1B, left graph). Further, similar results were obtained when HAT activity 
was tested on the H3 peptide in the presence of Gal4-VP16 activator and Gal4 DNA (Figure 1B, 
right graph). Therefore, Gal4-VP16 activator does not stimulate the HAT activity of SAGA in trans, 
but rather in cis.  
SAGA HAT module activity inhibited by activator  
Many subunits in SAGA have been shown to interact with activator proteins (Uesugi et al. 
1997; McMahon et al. 1998; Brown et al. 2001; Gamper and Roeder 2008), including Ada2 and Gcn5, 
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components of the HAT module (Barlev et al. 1995; Zhang et al. 2014). The simplest way 
activators could influence the rate of acetylation by SAGA would be through direct interactions 
with the HAT enzyme and/or module. We therefore recombinantly expressed and purified the 
Ada2/Ada3/Gcn5 HAT module with modifications to a previously described protocol in order to 
obtain more consistent HAT activities (Barrios et al. 2007). The complex of all three subunits was 
purified because both Ada2 and Ada3 are required to obtain the same substrate specificity and 
HAT activity on H3 peptide substrates as the SAGA exhibits (Balasubramanian et al. 2002).  
To characterize the baseline kinetic properties of the HAT module, initial rate, steady state 
kinetic experiments on increasing concentrations of GBY nucleosome were performed. The data 
was fit to the Michaelis-Menten equation (Figure 2A), resulting in a KM of 50 ± 15 nM and a kcat 
of 0.24 ± 0.04 min-1. In comparison to SAGA, the HAT module had 2.3-times weaker putative 
binding and a 4.2-times less efficient turnover rate. When increasing concentrations of Gal4-VP16 
activator were added to reactions of the HAT module and GBY nucleosomes, in stark contrast to 
stimulation of SAGA HAT activity, the rate of nucleosome acetylation decreased (Figure 2B, left). 
Inhibition is not simply due to non-specific disruption of the HAT module activity by protein, as 
increasing concentrations of a non-activator protein, BSA, to reactions of the HAT module and 
GBY nucleosomes doesn’t drastically alter the rate of acetylation (Figure 2B, right). 
Another possible reason for the decrease in activity is that the Gal4-VP16 activator could 
cause the HAT module to dissociate in solution. Gcn5 alone has approximately 4-times lower 
rates of acetylation on core histones (Balasubramanian et al. 2002). Thus, if the HAT module were 
being disrupted by Gal4-VP16, we would expect it to be reflected in its activity towards H3 
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peptide substrate. We didn’t observe such an effect with increasing concentrations of activator 
(Figure 2C), supporting our previous observation of the integrity of the HAT module. Because 
inhibition of HAT activity is observed on the GBY nucleosomes but not on the H3 peptides, we 
next probed the influence of activator on HAT module acetylation of 147 bp nucleosomes to see 
if flanking DNA was required. Like the GBY nucleosome, the addition of increasing concentrations 
of Gal4-VP16 activator to reactions of the HAT module and 147 bp nucleosomes decreased HAT 
activity (Figure 2D). This result suggested that activator inhibits the activity of the HAT module in 
a manner that does not require binding to its consensus sequence in the nucleosomal flanking 
DNA. 
Taken together, our results led us to consider a hypothesis where Gal4-VP16 activator 
binds non-specifically to the nucleosomes and that the HAT module is not able to clear non-
specifically bound Gal4-VP16 activator from nucleosomes. To test the first part of this hypothesis, 
we utilized an electrophoretic mobility shift (EMSA) assay as previously described (Mittal et al. 
2018). In this assay, increasing concentrations of Gal4-VP16 activator were incubated with GBY 
or 147 bp nucleosomes in the presence of excess CoA (Figure 3A). CoA was used in these assays 
to prevent turnover of acetyl CoA by the HAT module. As expected, Gal4-VP16 activator could 
bind to and shift unbound GBY nucleosomes to a bound state (Figure 3A, left lanes). We also 
observed that Gal4-VP16 activator could bind to 147 bp nucleosomes, albeit more weakly 
compared to the GBY nucleosomes (Figure 3A, right lanes). That we observed shift on 147 bp 
nucleosomes supported our model that Gal4-VP16 activator binds non-specifically to 
nucleosome substrates. To determine if Gal4-VP16 activator prevented the HAT module from 
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binding its nucleosome substrates, we next performed a pull-down assay using our bead-bound 
GBY nucleosomes (Figure 3B). Decreasing amounts of HAT module, as detected by a Gcn5-specific 
antibody, occurred concurrently with increasing amounts of Gal4-VP16 activator, as detected by 
SYPRO Ruby staining, supporting our hypothesis that the HAT module can’t clear non-specifically 
bound activators. 
ADA complex can clear non-specifically bound activators  
In contrast to SAGA, the HAT module activity was not stimulated by activator. It was also 
unable to clear non-specifically bound activators from nucleosomes. The HAT module doesn’t 
only exist in SAGA, but also comprises most the yeast ADA complex (Eberharter et al. 1999; Lee 
et al. 2011). We wanted to determine if the Gal4-VP16 activator influenced the HAT activity of 
ADA, and if ADA could clear non-specifically bound activators from nucleosome substrates. To do 
so, we first purified endogenous ADA complex from budding yeast and characterized its kinetic 
parameters towards GBY nucleosomes. Fitting the data to a Michaelis-Menten equation resulted 
in a KM of 116 ± 25 nM and a kcat of 1.3 ± 0.2 min-1 (Figure 4A). In comparison to SAGA, ADA has a 
very similar turnover rate while having a 5.3-times weaker apparent binding affinity for GBY 
nucleosomes. When increasing concentrations of Gal4-VP16 activator were added to reactions 
of ADA and GBY nucleosome, neither stimulation nor great inhibition of its activity was observed 
(Figure 4B). This result suggests that HAT activity of ADA, unlike that of SAGA, is not stimulated 
by Gal4-VP16 activator, but that, like SAGA, ADA can clear non-specifically bound activators from 
nucleosome substrates. 
Activator stimulates SAGA HAT activity through interactions with Tra1  
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Tra1 is the largest subunit of SAGA and has been shown to interact with many activator 
proteins, including Gal4-VP16 (McMahon et al. 1998; Saleh et al. 1998; Brown et al. 2001). 
Further, deletion of part of Tra1 resulted in decreased H3 acetylation at the promoters of genes 
in budding yeast while not influencing the localization of SAGA or its ability to interact with 
activators (Knutson and Hahn 2011). This suggests that in addition to interacting with activators, 
the Tra1 subunit also plays a role in the substrate specificity or HAT activity of SAGA. 
Endogenously expressed untagged SAGA complexes were purified containing either a 
wild type or mutant Tra1 subunit (tra1-2) (Brown et al. 2001). To ensure the innate HAT activity 
of SAGA was not affected by the Tra1 mutations in tra1-2, we performed HAT assays of the two 
SAGA complexes in the absence of Gal4-VP16 activator both on H3 peptide (Figure 5A) and GBY 
nucleosomes (Figure 5B). In both cases, the activity of the wild type and mutant strains did not 
vary significantly, demonstrating that the Tra1 mutations alone were not deleterious towards 
HAT activity. To test the ability of both strains to be stimulated by activator, increasing 
concentrations of Gal4-VP16 activator were added to the reactions of the SAGA complexes and 
GBY nucleosomes (Figure 5B). Like the other TAP-tagged SAGA experiments described above and 
previously (Mittal et al. 2018), Gal4-VP16 activator had a strong stimulatory effect on the HAT 
activity of the wild type Tra1 containing complex (Figure 5B, left). In contrast, the addition of 
increasing concentrations of Gal4-VP16 activator to tra1-2 containing SAGA complex and GBY 
nucleosomes resulted in a loss of two thirds of the stimulation of HAT activity (Figure 5B, right). 
Thus, our studies indicate that Tra1 is the major mediator of activator-dependent stimulation of 
acetylation turnover. 
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Discussion 
Eukaryotic gene expression requires the coordinated efforts of many proteins and protein 
complexes to overcome the repressive nature of chromatin. In this paper, we have probed how 
a single activator protein stimulates the HAT activity of the SAGA complex.  
Our results show that the HAT activity of SAGA is not significantly stimulated by activator 
when chromatin substrates lack flanking DNA. One possibility for this observation is that the 
binding to the flanking DNA itself makes activator active by, for example, inducing a 
conformational change in the activator protein. Such a conformational has been seen upon 
binding of the Gal4 activator to its consensus DNA; the structure of unbound Gal4(1-100) is more 
elongated compared to DNA-bound Gal4(1-100) (Hidalgo et al. 2001; Hong et al. 2008). However, 
our data seems to rule this out and support a model where DNA-binding by activator occurs in 
cis. This requirement is likely due to a need for the activator to be held proximal to the 
nucleosome for it to affect the HAT activity of SAGA. Increasing the local concentrations of 
activators near nucleosomes could also be critical to increasing the binding affinity of or 
stabilizing weak affinity interactions between the activation domain of VP16 and the Tra1 subunit 
of SAGA. It should be noted that, in this model of weak binding affinity between activator and 
SAGA, it could still be possible to see stimulation by driving binding interactions at high 
concentrations of activator. Indeed, our studies show that high concentrations of Gal4-VP16 
activator in reactions of SAGA and 147 bp nucleosome can increase the HAT activity up to two-
fold. However, full stimulation is not observed at high concentrations of activator and, coupled 
with our results that Gal4-VP16 activator binds non-specifically to nucleosomes, may be due to 
competition of nucleosome binding with SAGA. 
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That the Gal4-VP16 activator binds non-specifically to nucleosome substrates is not 
surprising because most eukaryotic genomic DNA is sequestered in chromatin. The DNA binding 
domains of many transcriptional activators have been structurally characterized; they are well 
ordered and most shown to bind specifically to unique series of bases in the major groove of DNA 
(Garvie and Wolberger 2001). In addition to interactions with the bases, DNA binding proteins 
also make extensive interactions with the negatively charged phosphate backbone of DNA 
(Luscombe et al. 2001), therefore not requiring nucleotide specificity. These results suggest that 
activators may sample the chromatin, non-specifically binding nucleosomes until they land upon 
their consensus DNA sequences. At these sites, they then recruit and/or interact with 
coactivators to influence their activities. Non-specific binding of activators may also inhibit 
untargeted enzymatic activities of chromatin modifying complexes, explaining why SAGA and 
ADA can compete for binding while the HAT module cannot.  
Though the majority of the subunits that comprise the ADA complex are the same four 
proteins of the SAGA HAT module, little is known about its HAT activity. Like SAGA, it has been 
shown to acetylate both free and nucleosomal histones (Grant et al. 1999; Lee et al. 2011). We 
too observe that ADA can acetylate nucleosome substrates. However, unlike SAGA, the addition 
of activator to reactions of ADA on nucleosomes does not stimulate its HAT activity. Considering 
that stimulation of SAGA HAT activity occurs predominantly through interactions of activator 
with the Tra1 subunit, this result makes sense. Further, no interactions have been observed 
between ADA and transcriptional activators (Utley et al. 1998), even though the Ada2 and Gcn5 
subunits has been shown to interact with the transcriptional activation domains (Silverman et al. 
94 
 
1994; Barlev et al. 1995; Gamper and Roeder 2008; Zhang et al. 2014). Activator also does not 
inhibit the HAT activity of ADA. These results support a model where ADA can clear non-
specifically bound activators from nucleosome substrates, potentially enabling ADA to play a role 
in the maintenance of global histone acetylation.  
Our analyses of the effects of activator on the ADA complex and the minimal HAT module 
led us to conclude that stimulation of HAT activity occurred through interactions of activator with 
a subunit outside of the HAT module. Many subunits in SAGA have been shown to interact with 
activators (Uesugi et al. 1997; McMahon et al. 1998; Brown et al. 2001; Gamper and Roeder 
2008). We specifically focused on the Tra1 subunit as it has been shown to interact with multiple 
activators (McMahon et al. 1998; Saleh et al. 1998; Brown et al. 2001) and mutations have 
perturbed the HAT activity of SAGA (Knutson and Hahn 2011). When activator was added to a 
mutant Tra1 containing SAGA complex, we did indeed observe diminished stimulation of HAT 
activity compared to wild type SAGA complex. Further work is required to determine if the other 
subunits of SAGA interact with activators to stimulate its HAT activity. 
Experimental procedures 
Nucleosome preparation  
Biotinylated GBY and 147 bp DNA was prepared as previously described (Mittal et al. 
2018). Briefly, recombinant Xenopus laevis histones were prepared (Luger et al. 1999a) and 
assembled into octamers (Luger et al. 1999b). Nucleosomes were assembled by depositing the 
histone octamer onto DNA by the process of rapid dilution and then dialyzed into LDB buffer (2.5 
mM NaCl, 10 mM Tris pH 7.4, 0.25 mM EDTA), as previously described (Blacketer et al. 2010). The 
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homogeneity and degree of saturation of nucleosome assemblies were asses via 4% Native PAGE. 
Nucleosomes were immobilized on hydrophilic streptavidin beads from NEB as previously 
described (Mittal et al. 2014). 
ySAGA and yADA preparation  
Endogenously expressed SAGA TAP-tagged on Spt7 and ADA complex TAP-tagged on Ahc1 
was expressed and purified as previously described (Wu and Winston 2002). Untagged SAGA 
complexes with wild type and mutant Tra1 subunits were expressed and purified as previously 
described (Eberharter et al. 1998). After anion column, 2 μl of every other fraction was tested for 
HAT activity on 50 μM H3 peptide in 11 μl reaction volume. Reactions were incubated at 30ᵒC for 
30 minutes before following protocol as previously described below. The purified enzymes were 
quantitated by Western blot (Santa Cruz Biotechnology sc-9078) in comparison to known 
amounts of recombinantly expressed and purified Gcn5 using.  
Recombinant HAT module and Gal4-VP16 purification  
Ada2/Ada3/Gcn5 complex was purified as previously described with some modifications 
(Barrios et al. 2007). In particular, after anion-exchange chromatography, pooled samples were 
concentrated to approximately 1 ml and applied to size-exclusion chromatography (GE Superdex 
200, 25 ml) in SEC buffer (300 mM NaCl, 20 mM HEPES pH  8.0, 0.1 mM EDTA, 2 ug/ml Pepstatin 
A, 2 ug/ml Leupeptin, 1 mM PMSF, 1 mM Benzamidine, 10 mM BME). Peak fractions were 
analyzed by SDS-PAGE and fractions containing recombinant sub-complex were pooled and 
concentrated. Concentrated samples were then mixed with glycerol to a final concentration of 
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50%. The purified enzyme complex was quantitated by western blot as above. Analysis by SEC-
MALS yielded a molecular weight of approximately 150 kDa. Addition of 15 μM NP-40 to HAT 
reactions was required to prevent non-specific binding of the HAT module to the magnetic 
streptavidin resin. Recombinant Gal4-VP16 was purified from E. coli XA90 cells transformed with 
pJL2S plasmid (a generous gift from Dr. Steve Treienberg) largely according to a previously 
published protocol (Dechassa et al. 2008).  
Steady state kinetics assays  
Assays were performed nearly the same as previously described (Mittal et al. 2018). 
Modifications to the assay include preincubating 18 μl of bead bound substrate at 2X the desired 
final concentration in LDB at 30ᵒC for 5 minutes with 18 μl of 2X HAT buffer (1X concentrations = 
25 mM Tris pH 8, 150 mM NaCl, 5% glycerol, 1 mM PMSF, 1 mM DTT, 10 mM sodium butyrate, 4 
μM AcCoA) with a specific activity of tritiated acetyl CoA of 13.9 – 22.6 Ci/mmol. The reactions 
were initiated with addition of 0.52 – 3.62 nM final enzyme. 8 μl aliquots were removed from the 
reaction and washed, counted, and initial rates calculated as previously described (Mittal et al 
2018). Assays on 20 μM H3 peptide (amino acids 1-20, Anaspec 62753) were performed similarly. 
18 μl 20 μM final H3 peptide in LDB was mixed 1:1 with 18 μl 2X HAT buffer (1X concentrations = 
25 mM Tris pH 8, 150 mM NaCl, 5% glycerol, 1 mM PMSF, 1 mM DTT, 10 mM sodium butyrate, 
12 μM AcCoA) with a specific activity of tritiated acetyl CoA of 13.9 – 22.6 Ci/mmol. 8 μl aliquots 
were spotted onto P81 phosphocellulose discs, washed twice in 300 ml wash buffer (4 mM 
sodium carbonate and 46 mM sodium bicarbonate, pH 9.2) for 20 minutes and once in 200 ml 
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acetone for 10 minutes. Discs were air-dried before being added to 3 ml liquid scintillation 
cocktail. Initial rates calculated as previously described (Mittal et al 2018).  
EMSA and pull-down assays  
EMSA assays of Gal4-VP16 (0, 20, 100, 200, 400 nM) activator and 5 nM GBY or 147 bp 
nucleosomes were performed as described previously (Mittal et al. 2018). Pull-down assays of 11 
nM HAT module by 20 nM GBY nucleosome and increasing concentrations of Gal4-VP16 activator 
(0, 40, 100, 200 nM) were performed in buffers nearly identical to the steady state kinetics assays; 
15 μl 20 nM final GBY nucleosomes in LDB mixed 1:1 with 2X HAT buffer (1X concentrations = 25 
mM Tris pH 8, 150 mM NaCl, 5% glycerol, 1 mM PMSF, 1 mM DTT, 10 mM sodium butyrate, 4 μM 
CoA). 
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Figures 
 
Figure 1. Stimulation of SAGA HAT activity by Gal4-VP16 activator occurs in cis. (A) Effects of Gal4-
VP16 on acetylation of substrates with and without flanking DNA. Initial rates of SAGA acetylation 
on GBY nucleosomes (left graph, left lanes), 147 bp nucleosomes (left graph, right lanes), and H3 
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peptide (right graph), with increasing concentrations of Gal4-VP16. Error bars here and 
throughout represent the standard deviation of at least three trials. (B) Characterization of 
stimulation by Gal4-V16 in presence of exogenous activator DNA. Initial rates of SAGA acetylation 
on 147 bp nucleosomes (left graph) and H3 peptide (right graph) in the presence of Gal4-VP16 
with increasing concentrations of a 17 bp DNA oligo containing the Gal4 consensus binding 
sequence (Gal4 DNA). 
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Figure 2. HAT module HAT activity is inhibited by Gal4-VP16 activator. (A) Steady state kinetics 
of GBY nucleosome acetylation by HAT module. Initial rates of HAT module-mediated acetylation 
were plotted at varying GBY nucleosome concentrations and fit to the Michaelis-Menten 
equation. (B) Effects of Gal4-VP16 on acetylation of GBY nucleosomes. Initial rates of HAT module 
acetylation on GBY nucleosome with increasing concentrations of Gal4-VP16 (left) or bovine 
serum albumin (BSA; right). (C) Effects of Gal4-VP16 on acetylation of H3 peptide. Initial rates of 
HAT module acetylation on H3 peptide with increasing concentrations Gal4-VP16. (D) Effects of 
Gal4-VP16 on acetylation of 147 bp nucleosome. Initial rates of HAT module acetylation on 147 
bp nucleosome with increasing concentrations of Gal4-VP16. 
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Figure 3. Gal4-VP16 activator binds non-specifically to nucleosomes and inhibits HAT module 
binding. (A) Nucleosome binding by Gal4-VP16. EMSA of GBY (left) and 147 bp (right) 
nucleosomes with increasing concentrations of Gal4-VP16. EMSA performed on composite gel 
and stained with SYBR Gold stain. (B) Effects of non-specific nucleosome biding by Gal4-VP16. 
HAT module pulled down by bead-bound GBY nucleosomes with increasing concentrations of 
Gal4-VP16. Amounts of HAT module detected by Gcn5-specific antibody, Gal4-VP16 detected by 
SYPRO Ruby stain, and GBY nucleosomes detected by H3-specific antibody. 
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Figure 4. ADA complex HAT activity not altered by Gal4-VP16 activator. (A) Steady state kinetics 
of GBY nucleosome acetylation by ADA complex. Initial rates of ADA-mediated acetylation were 
plotted and fit as in 2A. (B) Effects of Gal4-VP16 on GBY nucleosome acetylation. Initial rates of 
ADA acetylation on GBY nucleosomes with increasing concentrations of Gal4-VP16.  
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Figure 5. Stimulation of SAGA HAT activity occurs predominantly through interactions of Gal4-
VP16 activator with Tra1 subunit. (A) Comparison of wild type Tra1-containing SAGA and mutant 
tra1-2-containing SAGA HAT activity on H3 peptide. Initial rates of SAGA complexes on H3 
peptide. (B) Effects of Gal4-VP16 on GBY nucleosome acetylation by Tra1-containing and tra1-2-
containing SAGA. Initial rates of SAGA complexes on GBY nucleosomes with increasing 
concentrations of Gal4-VP16. 
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CHAPTER 4. CURRENT WORK AND FUTURE DIRECTIONS 
Additional controls and experiments for publications of Chapters 2 and 3 
 We are currently performing controls requested by reviewers for the publication of 
Chapter 2. Specifically, we seek to analyze the abilities of the activation and DNA binding domains 
to stimulate the HAT activity of SAGA in isolation. GST-VP16 has been obtained (Sigma-Aldrich 
SPR2121-10UG) and initial HAT assays performed; no stimulation of HAT activity has been 
observed (Figure 1A). We have acquired plasmids containing His-tagged and GST-tagged Gal4 
DNA binding domains from Dr. Jose Leonardo “Leo” Gutierrez (formerly from Dr. Jerry 
Workman’s laboratory), and will be expressing, purifying, and characterizing these domains on 
the HAT activity of SAGA. 
 Additional controls and experiments are being and will be performed to complete the 
story detailed in Chapter 3. To compliment the results of the HAT assay of the HAT module on 
histone H3 with increasing concentrations of activator, we have performed a pull-down assay. 
This assay demonstrates that our HAT module is intact and inhibition of HAT activity does not 
occur due to disruption of the HAT module by activator (Figure 1B). Another pull-down assay of 
ADA complex by bead-bound GBY nucleosomes provides evidence that ADA can clear non-
specifically bound activators from nucleosomes (data not shown); imaging must be further 
optimized. We will characterize the HAT activity of the HAT module upon addition of increasing 
concentrations of GST-VP16 and a Gal4 DNA binding domain. Finally, we will perform pull-down 
assays of wild type and mutant Tra1 containing SAGA complexes by GST-VP16 to determine if 
interactions are completely disrupted. 
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SAGA-activator interactions 
In our analysis of subunits required for the stimulation of SAGA HAT activity by the Gal4-
VP16 activator, we used a mutant Tra1-conatining SAGA strain that contained seven different 
point mutants (Brown et al. 2001). Upon comparing the HAT activity of the wild type Tra1 and 
tra1-2 containing SAGA on GBY nucleosomes with increasing concentrations of Gal4-VP16 
activator, we observed that there was decreased stimulation of the HAT activity of the mutant 
Tra1-contianing complex (see Chapter 3, Figure 5B). That we still see some stimulation of HAT 
activity upon addition of Gal4-VP16 activator suggests two things: (1) other subunits in SAGA still 
interact with activator to stimulate SAGA HAT activity or (2) the binding interface between our 
mutant Tra1-containing SAGA and Gal4-VP16 activator is not completely abrogated.  
Future work in the lab will seek to address if and which other subunits in the complex 
interact with Gal4-VP16 activator to stimulate the HAT activity. Additionally, mutagenesis of the 
Tra1 subunit can be directed to characterizing the binding interface between Gal4-VP16 activator 
and Tra1. 
SAGA-activator substrate specificity  
Many questions remain as to how activator stimulates the HAT activity of SAGA. The 
positioning and number of the DNA consensus sequence(s) is one. Future studies could probe 
how moving the 17 bp DNA consensus sequence closer to or further away from the nucleosomes 
in the flanking DNA affects the HAT activity of SAGA. Further, the consensus sequence could be 
moved into the 147 bp of DNA that wraps the nucleosome to see if Gal4-VP16 activator can bind 
to and stimulate SAGA HAT activity. Many gene promoters also have more than one activator 
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binding sequence in their UAS (Marmorstein et al. 1992); addition of multiple DNA consensus 
sequences could be added to the flanking DNA of target nucleosomes to see if binding of multiple 
activators to the flanking DNA further increases the rate of acetylation by SAGA. 
The studies performed in Chapters 2 and 3 consist of only single nucleosomes with the 
DNA consensus sequence for Gal4 in flanking DNA on one side of the nucleosome. This work 
could be expanded to nucleosome arrays as designed in Mittal et al 2014 (Mittal et al. 2014). For 
example, the trimeric nucleosome arrays made there include the GBY nucleosome, and the 
addition of activator to those reactions could determine if activator potentiates stimulated 
acetylation to multiple nucleosomes or just the nucleosome adjacent to the DNA consensus 
sequence. Further, the Gal4 DNA consensus sequence could be placed in the flanking DNA 
between two nucleosomes and acetylation sequencing could be performed to determine if 
activator stimulated the HAT activity of SAGA on one or both nucleosomes that flank the DNA 
consensus sequence.  
Structural analysis of stimulation of SAGA HAT activity by flanking DNA and activator 
Since the early 2000s, multiple groups have studied the molecular architecture of the 
SAGA complex by negative stain EM (Wu et al. 2004; Durand et al. 2014; Setiaputra et al. 2015). 
Only recently has the structure of SAGA been analyzed using cryo-EM (Diaz-Santin et al. 2017; 
Sharov et al. 2017). Even so, only one group thus far has been able to observe SAGA interaction 
with a nucleosome (Durand et al. 2014), and only one other has studied the interaction of SAGA 
with activators (Setiaputra et al. 2015). We demonstrate the first biochemical analysis that SAGA 
interacts with and binds to nucleosome substrates with tight affinity (see Chapter 2, Figure 1C).  
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With this observation and set of conditions in which binding occurs, we want to pursue 
our own EM studies on the SAGA complex. First, we seek to optimize and characterize the 
molecular architecture of SAGA alone. We then want to study the interactions of SAGA with 
different nucleosome substrates, including the GBY and 147 bp nucleosomes. We want to test 
both nucleosomes as we have observed that SAGA has higher activity on GBY nucleosomes, that 
SAGA requires flanking DNA on both sides of the nucleosome (see Chapter 2, Figures 2B, 3B, and 
3C), and that SAGA binds to DNA (data not shown). We hypothesize that SAGA binding to the 
DNA stimulates the HAT activity of SAGA. Thus, studies characterizing the interaction between 
SAGA and its substrates would be instrumental in expanding our working model.  
Further, we observe that activator stimulates SAGA HAT activity by increasing the kcat of 
the reaction, not decreasing the KM, as was the general hypothesis (see Chapter 2, Figure 4D). 
Though many factors for the stimulation of SAGA HAT activity by activator have been 
characterized, it is not yet known how activator stimulates SAGA. The interaction of activator 
with SAGA could create a persistent and highly active form of SAGA, potentially via self-
acetylation or other related manner. We believe this is not the case based on the results of a HAT 
assay. In this assay, GBY nucleosomes and cold acetyl CoA were preincubated at 30ᵒC for five 
minutes with or without Gal4-VP16 and the reaction was initiated with SAGA. After three 
minutes, 17 bp DNA oligo containing the Gal4-VP16 consensus sequence was or was not added 
in excess to the reaction and allowed to sequester Gal4-VP16 for five minutes. The entire reaction 
was then mixed 1:1 with a greater concentration of GBY nucleosomes and radiolabeled acetyl 
CoA and aliquots were removed at specific time points. If Gal4-VP16 created a persistent and 
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highly active form of SAGA, we would expect increased activity in the reactions that included 
Gal4-VP16. Though only done once each, the results do not show differences between reactions 
with or without Gal4-VP16.  
Alternatively, interaction of activator with the Tra1 subunit of SAGA could induce an 
allosteric conformational change that is perpetuated through the complex to the HAT module. 
This conformational change could correctly position the HAT module, lock the HAT module into 
place, or generate an active site with altered structure that reduces a potential rate limiting step. 
This hypothesis is not unreasonable as groups have previously observed that (1) SAGA possesses 
conformational flexibility, primarily in the HAT domain region (Setiaputra et al. 2015), and (2) the 
binding of an activator to yeast Mediator complex induces a conformation change in subunits 
distal to the site of activator interaction (Tsai et al. 2014). Because we believe the interaction 
between SAGA and activator to be weak, we will study the EM structure of SAGA with activator, 
both with and without GBY nucleosome substrate. 
SAGA-RNA interactions 
During the development of our EMSA assays described in Chapters 2 and 3, we observed 
that SAGA co-purified with nucleic acid (Figure 2A, lane 10). SAGA samples were subjected to 
digests by micrococcal nuclease (MNase; cleaves double-stranded (ds) and single-stranded (ss) 
nucleic acids) and ribonuclease A (RNase A; cleaves ssRNA) to determine what type of nucleic 
acid co-purified with SAGA. We observed that both MNase and RNaseA could cleave the nucleic 
acid samples in SAGA (Figure 2B), suggesting that SAGA co-purifies with ssRNA. 
113 
 
That SAGA co-purifies with ssRNA is not unreasonable. In yeast, greater than 85% of its 
genome is transcribed but only a few percent of the total transcribe RNA is messenger RNA 
(mRNA). The rest of it is non-coding RNA (ncRNA). There are many types of ncRNAs including 
short ncRNAs like micro RNA (miRNA) and small interfering RNA (siRNA), medium ncRNA such as 
transfer RNA (tRNA), and long ncRNA (lncRNA). lncRNAs can also be grouped into four main types:  
enhancers, scaffolds, decoys, and guides (Rinn and Chang 2012). Of these, other yeast coactivator 
complexes, such as Mediator complex, has been shown to interact with enhancer lncRNAs to 
promote chromatin looping in eukaryotic gene expression (Darrow and Chadwick 2013; Lai et al. 
2013). Further, yeast Mediator and SAGA complexes both localize to UAS regions upstream of 
gene promoters (Grunberg et al. 2016; Baptista et al. 2017). 
We want to determine the role RNA plays in the enzymatic functions and protein 
interactions of the SAGA complex and identify the RNA if it is indeed a specific RNA. Towards that 
end, we first purified SAGA samples without RNA by including RNase A in the IgG and/or 
calmodulin resin binding steps of the published SAGA purification protocol (Figure 3A). A silver 
stain demonstrates that treatment of SAGA with RNase A does not change its subunit 
composition (Figure 3B). We next probed if the removal of RNA affected the rate of the HAT 
activity of SAGA as described in Chapters 2 and 3. Briefly, in these assays, GBY or 147 bp 
nucleosomes were pre-incubated with radiolabeled acetyl CoA, and the reaction was initiated 
with the addition of SAGA with or without RNase A treatment in its purification (Figure 3C). We 
observed that the activity of the two SAGA samples were unchanged on the nucleosome 
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substrates, suggesting that the RNA present in the SAGA sample doesn’t alter the HAT activity of 
SAGA.  
We also pilot tested the ability of Gal4-VP16 activator to stimulate SAGA HAT activity in 
the presence or absence of RNA (Figure 3D). Like untreated SAGA, RNase A treated SAGA does 
not exhibit stimulation of HAT activity on 147 bp nucleosomes, supporting the model that Gal4-
VP16 activator must bind its consensus sequence in the flanking DNA of the target nucleosome. 
However, our pilot assays of SAGA samples on GBY nucleosome with addition of Gal4-VP16 
activator suggest that RNA may play a role in the interaction of SAGA with activators. In these 
assays, we observe that the rate of stimulation by Gal4-VP16 activator is reduced in the SAGA 
sample that has been treated with RNase A. 
SAGA not only possesses HAT activity but also has deubiquitination (DUB) activity. To 
determine if the co-purifying RNA played a role in the ability of SAGA to perform this activity, we 
optimized a DUB assay (Figure 3A). In this assay, 50 μM of K48-linked di-ubiquitin (LifeSensors) 
was preincubated at 30ᵒC for 5 minutes in 17 μl of 25 mM Tris pH 7.4, 150 mM NaCl, and 1 mM 
DTT. SAGA with or without RNase A treatment in purification was then added to the reaction to 
25 nM final, and aliquots of 4 μl were removed at 15, 45, and 120 minute time points. The aliquots 
were quenched by mixing with 3X protein loading dye and all of each sample was loaded onto a 
1 mm 12% SDS-PAGE gel. The gel was ran for 40 minutes at 180 V at room temperature and 
subsequently silver stained (Figure 3B). The relative amounts of cleaved samples (mono-
ubiquitin) were calculated by density analysis on Image J. After comparing the amounts of mono-
ubiquitin between the two SAGA samples, it is observed that untreated SAGA possesses 
115 
 
approximately 1.8 – 2.4-times greater ability to cleave K48-linked di-ubiquitin relative to SAGA 
treated with RNase A in its purification. Potentially, RNA plays a role in stimulating both the HAT 
and DUB enzymatic activities of SAGA. Further work will need to be performed to determine if 
RNA indeed plays a role in the DUB activity of SAGA. 
Future work on this project would aim to determine if the co-purifying RNA acts to bridge 
SAGA complex to other transcription machinery, such as activators, SWI/SNF, Mediator, the GTFs, 
or even the chromatin itself. Identification of other co-purifying complexes could be analyzed at 
different steps in the purification process by either probing with subunit specific antibodies or 
via multidimensional protein identification technology (Mud-PIT) analysis. Further, we want to 
identify the RNA that co-purifies with SAGA if it is a specific RNA molecule and not non-specific 
binding of RNA to SAGA. Identification of the RNA could be approached in two manners: (1) after 
RNA immunoprecipitation (RIP), the RNA could be reverse transcribed using primers specific to 
RNA sequences or (2) RIP could be coupled to sequencing. The caveat of the first method is that 
the primers used in RT-PCR would be created based on educated guesses of which RNA SAGA 
interacts with; RIP-seq would enable identification of unknown RNA. 
Burst phase kinetics 
In Chapter 2, we observe that SAGA possesses burst phase kinetics on nucleosomes. We 
suggest two plausible mechanisms for this burst phase: (1) the rate of acetylation of SAGA on a 
single lysine side chain is increased (H3K14ac) and the remaining acetylation events are rate 
limiting or (2) acetylation by SAGA is processive and multiple acetylations occur prior to 
nucleosome release. We seek to identify which mechanism is correct by using acid urea (TAU) 
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gels. TAU gels can separate differentially acetylated histone H3 from unacetylated histone H3. 
When run against a ladder of un-, mono-, di-, tri-, and tetra-acetylated histone H3 proteins (Young 
et al. 2016), the mechanism may be determined. For example, if SAGA acetylated all H3K14 at a 
fast rate and was slow on the remaining lysines, we would expect to see the entire population of 
histone H3 in our HAT assays to shift from unacetylated to monoacetylated at early time points, 
and then observe additionally acetylated populations at later time points. Alternatively, if SAGA 
was processive in acetylating histone H3, then we would expect to see a large population of 
histone H3 remain unacetylated at early time points with a small population being rapidly multi-
acetylated. 
Towards that end, we have performed TAU gels and probed for histone H3 acetylation 
levels in the following manners. TAU gel composition and pre-running protocol are from Shogren-
Knaak’s notes (3/11/2004) and Center for Cocoa Biotechnology Research and Development: 
Molecular Biology: Working with Proteins: Protein Detection: Gel Electrophoresis: Triton-Acetic 
Acid-Urea (TAU) Gel Electrophoresis of Histones: 
1. Make TAU gel (13.5% acrylamide, 0.08% bis-acrylamide, 7.5M urea, 0.375% Triton X100, 
5% glycerol) 
a. Filter and degas for 30 minutes 
b. Add polymerizing agents (0.12% APS, 0.45% TEMED) 
c. Let polymerize several hours 
2. Assemble gel rig and add 5% acetic acid to chambers 
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3. Add 70 μl overlay solution to each well (0.02% pyronine Y (w/v), 7.5M urea, 0.375% Triton 
X100, 5% glycerol) 
4. Run gel 19 hours at 4ᵒC at 100 V with reversed leads 
5. Add 70 μl scavenging solution to each well (1M cysteamine HCl, 7.5M urea, 0.375% Triton 
X100, 5% glycerol) 
6. Run gel 24 hours at 4ᵒC at 100 V with reversed leads 
Histone H3 (mono- to multi-acetylated) samples have been TCA precipitated or simply diluted 
into loading dye (0.01% pyronine Y, 7.5 M urea, 5% BME, 0.4% Triton X100, 5% glycerol). 
Nucleosome containing reactions have been quenched by mixing 1:1 in 2X loading dye (0.02% 
pyronine Y, 7.5M urea, 10% BME, 0.8% Triton X100, 10% glycerol). TAU gels are then run for 24 
hours at 4ᵒC at 200 V with reversed leads. 
TAU gels have been analyzed multiple ways. Successful detection of proteins have been 
probed by Coomassie staining of TAU gels, and by western blot. 
1. Coomassie staining of TAU gels 
a. Incubate in Coomassie stain overnight at room temperature 
b. Destain (10% acetic acid, 30% methanol) until histone proteins are visible (6+ 
hours) 
2. Western blotting of TAU gels 
a. Wash TAU gel 2 times in 250 ml WB1 for 30 minutes each (0.5% SDS (w/v), 50 mM 
acetic acid, glacial) 
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b. Wash 3 times in 150 ml WB2 30 minutes each (5% BME, 2% SDS, 62.5 mM Tris pH 
6.8) 
c. Cut gel to nitrocellulose membrane dimensions 
d. Transfer, block, and apply antibodies as per normal protocol 
TAU gels have unsuccessfully been probed by silver stain (SJC protocol) or by cobalt stain 
(Center for Cocoa Biotechnology Research and Development). 
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Figures 
 
Figure 1. Controls and experiments for Chapters 2 and 3. (A) Effects of GST-VP16 on HAT activity 
of SAGA. Increasing concentrations of GST-VP16 does not alter HAT activity of SAGA. (B) HAT 
module integrity maintained upon addition of Gal4-VP16. Increasing concentrations of Gal4-VP16 
to reactions of HAT module and GBY does not disrupt integrity of the HAT module.  
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Figure 2. SAGA co-purifies with RNA. (A) SAGA co-purifies with nucleic acid. SAGA only control 
(lane 10) stains with SYBR Gold nucleic acid stain in EMSA (performed as described in Chapter 2). 
(B) Characterization of nucleic acid. SAGA samples submitted to digestion by RNase A or MNase 
run on composite gel.  
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Figure 2. Comparing SAGA ± RNase A treatment. (A) Analysis of SAGA purified with RNase A. 
Parallel purifications of SAGA with RNase A; RNase A included in both IgG and CMA binding steps 
eliminates most co-purifying RNA. (B) SAGA integrity maintained upon treatment with Rnase A. 
Addition of RNase A to purification does not change integrity of SAGA complex as determined by 
silver stain on 12% SDS-PAGE gel. (C) Effects of RNase A treatment on SAGA HAT activity. SAGA ± 
RNase A has no difference in HAT activity on either GBY or 147 bp (147M) nucleosomes. (D) 
Effects of RNase A treatment on stimulation of HAT activity by activator. SAGA ± RNase A may 
exhibit difference in stimulation by activator complex on GBY nucleosomes but not on 147 bp 
nucleosomes. 
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Figure 3. SAGA ± RNase A may have different DUB activity. (A) DUB assay scheme. (B) SAGA ± 
RNase A have approximately 2-times different cleavage of Di-Ub to Mono-Ub.  
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CHAPTER 5. CONCLUSIONS 
Eukaryotic gene expression requires the coordination of many proteins and protein 
complexes. These include DNA-binding activators, co-activator complexes, the general 
transcription machinery, and RNA polymerase II. Though many of these factors have been 
identified and localized to the promoter regions, we remain limited in our knowledge as to how 
these proteins interact with one another and the chromatin to influence their individual 
activities. Our report described herein demonstrates our attempts to understand how the HAT 
activity of one co-activator complex, the SAGA complex, is influenced by the chromatin structure 
and by a specific transcriptional activator.  
In our studies, we have developed and utilized acetylation assays to detect the HAT 
activity of SAGA on numerous chromatin substrates. These substrates include a histone peptide 
and multiple nucleosomes with varying flanking DNA lengths and sequences. We have also 
developed protein binding assays to detect interactions between SAGA and nucleosomes, and 
between a transcriptional activator and nucleosomes. Further, we have analyzed the effects of a 
transcriptional activator on the HAT activity and nucleosome binding of SAGA. These studies have 
allowed us to characterize how the chromatin environment and a transcriptional activator 
influence the rate of acetylation by SAGA. 
Previously, we have observed that DNA flanking a nucleosome could stimulate the HAT 
activity of SAGA. We further characterized the effects of flanking DNA and observed that SAGA 
had both increased apparent binding affinity for and increased turnover rate on a GBY 
nucleosome, a chromatin substrate with 95 bp of flanking DNA on one side and 15 on the other, 
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compared to a 147 bp nucleosome, which contained no flanking DNA. Shift assays further 
demonstrated that SAGA bound GBY nucleosomes tighter than 147 bp nucleosomes. Closer 
analysis of this stimulation demonstrated that flanking DNA stimulates the HAT activity of SAGA 
at different stages of the reaction; the rate of acetylation on GBY nucleosome is amplified during 
both the burst phase and the steady state phases compared to the 147 bp nucleosome. It was 
also determined that at least 15 bp of flanking DNA on each side of the nucleosome was required 
to stimulate the HAT activity of SAGA past that of the 147 bp nucleosome. 
Inclusion of the transcriptional activator, Gal4-VP16, to HAT assays on GBY nucleosome, 
a nucleosome which contained a 17 bp consensus sequence for the yeast activator Gal4, 
stimulated the HAT activity of SAGA. However, in this case, only the turnover rate of the reaction 
increases; the apparent binding affinity of SAGA for GBY nucleosome doesn’t change with 
addition of activator. Shift assays further supported this model. Additionally, the addition of 
activator to reactions of SAGA and GBY nucleosomes does not change the apparent binding 
affinity of SAGA for acetyl CoA. These results contrast to the prevailing model of activator 
stimulation of HAT activity in which the binding affinity of SAGA for its chromatin substrates 
increased. 
Stimulation of the HAT activity of SAGA by activator appears to be dependent on a 
number of variables. First, we observed the stimulation is indeed dependent on the activator 
protein, as addition of increasing concentrations of a non-activator protein does not change the 
HAT activity of SAGA. Second, stimulation of SAGA HAT activity requires activator to bind to its 
consensus sequence in the flanking DNA of the target nucleosome; activator alone or bound to 
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its consensus sequence is unable to stimulate HAT activity in trans. Third, the interaction of 
activator with the Tra1 subunit of SAGA appears to be responsible for the majority of the 
stimulation of HAT activity. 
During the course of these studies, we also observed that activator proteins bound non-
specifically to nucleosome substrates, regardless of whether or not they had flanking DNA 
containing its consensus sequence. The non-specific binding of activators to GBY nucleosome 
inhibit the HAT activity of the HAT module because the HAT module is unable to clear non-
specifically bound activators to bind to and perform acetylation on nucleosomes. However, that 
the HAT activity of SAGA and ADA is not altered suggest that they can clear non-specifically bound 
activators from chromatin substrates to perform their innate rates of acetylation. 
Eukaryotic gene expression is a complex cellular event that requires many factors. At this 
time, our knowledge is limited as to how this event is coordinated in cells. The results detailed in 
this dissertation expand our knowledge on how one transcriptional activator influence one 
activity of one coactivator complex. Much more work is required to characterize how proteins 
and protein complexes interact with one another, how these interactions influence their 
individual activities, and how the chromatin environment contributes both the interactions and 
activities.  
 
